👤 Tieqiao Wang

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧪 BiometalDB 🧬 Extraction
4397
Articles
2763
Name variants
Also published as: Junli Wang, Xindi Wang, Junpeng Wang, Tingyu Wang, Guoqiang Wang, Yuxuan Wang, Hanzhi Wang, Zhi-Long Wang, Shanshan Wang, Wenfei Wang, Dengbin Wang, Yen-Sheng Wang, Chuanxin Wang, Zeyu Wang, Beibei Wang, Taicheng Wang, Xingguo Wang, Z P Wang, Yue-Min Wang, Chenghua Wang, Xianqiang Wang, Congrong Wang, Yanhai Wang, Du Wang, Xianzhe Wang, Zuoheng Wang, Yongyi Wang, Zhihui Wang, Yanhua Wang, Limeng Wang, H J Wang, Pei-Jian Wang, Yana Wang, Congrui Wang, Larry Wang, Yu-Zhuo Wang, Sihua Wang, Wanchun Wang, Jialin Wang, Xinying Wang, Shuguang Wang, Yinhuai Wang, Xiaobin Wang, Yuying Wang, Hebo Wang, Leli Wang, Jiayu Wang, Zhaojun Wang, Hai Wang, Si Wang, Re-Hua Wang, Xuping Wang, Bo Wang, Shubao Wang, Songjiao Wang, Hongjia Wang, Victoria Wang, Ling Wang, Jianjie Wang, Haining Wang, Dali Wang, Ji-Yang Wang, Cheng Wang, Weifan Wang, Yuanqiang Wang, Zhixiao Wang, Yaxian Wang, Zhigang Wang, Haochen Wang, Jia-Ying Wang, Shichao Wang, Ruosu Wang, N Wang, Haixing Wang, Guiqun Wang, Zhiting Wang, Dan Wang, Wangxia Wang, Jing-Long Wang, Yaqian Wang, Yafang Wang, Xing-Jun Wang, Dapeng Wang, Zhongyuan Wang, Junsheng Wang, Zhaohai Wang, He-Ping Wang, Minmin Wang, Wenzhou Wang, Zhaohui Wang, Yanfang Wang, Pengtao Wang, Leran Wang, Qianwen Wang, Hongkun Wang, Sa Wang, Y Alan Wang, Liyan Wang, Jou-Kou Wang, Mingda Wang, Chenfei Wang, Yuehan Wang, Simeng Wang, Yuhua Wang, Ruibin Wang, Haibo Wang, Ni Wang, Guoxiu Wang, Zhuangzhuang Wang, Yajie Wang, Zhixiang Wang, Sangui Wang, Xiantao Wang, Yan-Yang Wang, Mengjun Wang, Ruling Wang, Peihe Wang, Miao Wang, Zaihua Wang, Jun-Jie Wang, Mengyao Wang, Zhiyu Wang, Changzhen Wang, Xijun Wang, Chengjian Wang, Yiyi Wang, Mo Wang, Xiaolun Wang, Danan Wang, Fanchang Wang, Zilin Wang, Fanhua Wang, Supeng Perry Wang, Gavin Wang, Yi-Ying Wang, Yani Wang, Zhuowei Wang, Weiwei Wang, Haifeng Wang, Yi-Shiuan Wang, Yan-Chao Wang, Xiaotong Wang, Jia-Qi Wang, Yongliang Wang, Yongming Wang, Fengchong Wang, Jianyong Wang, Zeping Wang, Huaquan Wang, Xiaojia Wang, Tao Wang, Tianjun Wang, Siying Wang, Zhenze Wang, Zhijian Wang, Li Wang, Heming Wang, Jingtong Wang, Xuefei Wang, Yingqiao Wang, Xiao Qun Wang, Chun-Chieh Wang, Shuang-Xi Wang, Laiyuan Wang, Zhaoming Wang, Yinggui Wang, Qi-Jia Wang, Wen-Yan Wang, Mingming Wang, Peipei Wang, Chien-Hsun Wang, Qiuhong Wang, Monica Wang, Lexin Wang, Xiufen Wang, Yuehua Wang, Pingfeng Wang, Caiyan Wang, Weijie Wang, Yigang Wang, Jieyan Wang, Huiquan Wang, Chunsheng Wang, Yunhe Wang, Changtu Wang, Qingliang Wang, Guanghua Wang, Yongbin Wang, Zhaobo Wang, Minghui Wang, Junshi Wang, Jingyu Wang, Longsheng Wang, Fen Wang, Xianshu Wang, Jianwu Wang, Jun-Zhuo Wang, Zhixing Wang, Lei Wang, Yiyan Wang, Jinglin Wang, Jinhe Wang, Enhua Wang, Yuecong Wang, Xueying Wang, Jennifer T Wang, Xin-Hua Wang, Shijie Wang, Chun-Xia Wang, Yuanjiang Wang, Xiaojun Wang, Shunjun Wang, Chun-Juan Wang, M Wang, Jinfei Wang, Jinghuan Wang, Xuru Wang, Xiao-Lan Wang, Yu-Chen Wang, Zhi-Guo Wang, Luya Wang, Shuwei Wang, Pingchuan Wang, Qifan Wang, Xing-Quan Wang, Weiding Wang, Xuebin Wang, Yaling Wang, Chenyin Wang, Allen Wang, Liyuan Wang, Rong-Rong Wang, Wusan Wang, Wayseen Wang, Qianru Wang, Yi-Xin Wang, Hailin Wang, Yu-Hang Wang, Xuesong Wang, Haojie Wang, Wanxia Wang, Mengwen Wang, Hanping Wang, Yuhang Wang, Lueli Wang, Xinchang Wang, Oliver Wang, Shuge Wang, Jianhao Wang, Chong Wang, Kui Wang, Litao Wang, Zining Wang, Ming-Yang Wang, Hongxia Wang, Mingyi Wang, Hai Bo Wang, Bingnan Wang, Hongqian Wang, Jisheng Wang, Jiakun Wang, Maoju Wang, Xiaoqiu Wang, Dongyi Wang, Hai Yang Wang, Pengju Wang, Xiaofeng Wang, Huming Wang, Jian'an Wang, Qianrong Wang, Xiaowei Wang, Xiangkun Wang, Da Wang, Hongying Wang, Changying Wang, Changyu Wang, Xiaoqin Wang, Zhenxi Wang, Qiaoqiao Wang, Yu Tian Wang, Yupeng Wang, Xinli Wang, YueJiao Wang, Jian-chun Wang, Pengchao Wang, Xiao-Juan Wang, Siqing Wang, C Z Wang, Pengbo Wang, Baoli Wang, Yu-Zhe Wang, Gui-Qi Wang, Dazhi Wang, Yanwen Wang, Xingqin Wang, Shijin Wang, Wenming Wang, Fanxiong Wang, Tiansong Wang, Shuzhe Wang, Jie Wang, Jinling Wang, Yunfang Wang, Luyao Wang, Cun-Yu Wang, Zikang Wang, Quan-Ming Wang, Yingying Wang, Chia-Chuan Wang, Xintong Wang, Jufeng Wang, Xuejun Wang, Xiao-Qian Wang, Yijin Wang, Meng Yu Wang, Tianyi Wang, Chia-Lin Wang, Zhuo-Jue Wang, Yaohe Wang, Rong Wang, Hao-Hua Wang, Yong-Jun Wang, Xubo Wang, Dalong Wang, Yan-Ge Wang, Erika Y Wang, Ruixian Wang, Jin-Liang Wang, Shicung Wang, Saifei Wang, Jintao Wang, Zhenzhen Wang, Jiawei Wang, Beilei Wang, Huabo Wang, Huiyu Wang, Hongtao Wang, Chengjun Wang, Guo-Du Wang, Taoxia Wang, Zitao Wang, Jingwen Wang, Yibin Wang, Long Wang, Xinjing Wang, Qunzhi Wang, Liangliang Wang, Bangchen Wang, Yu-Fen Wang, Shibin Wang, Congcong Wang, Xiong Wang, Zhiren Wang, Xiaozhu Wang, Hong-Xia Wang, Qingyong Wang, Tianying Wang, Tammy C Wang, Huijie Wang, Tiansheng Wang, Mengzhao Wang, Jianshu Wang, Xinlong Wang, Benzhong Wang, Zhipeng Wang, Kaijie Wang, Xiaomin Wang, Peijun Wang, Zhiqiang Wang, Jundong Wang, Zheng Wang, Yueze Wang, Sujuan Wang, Qing-Yun Wang, Xiaoqing Wang, Zongqi Wang, Zhicun Wang, Fudi Wang, Seok Mui Wang, Wanbing Wang, Kejun Wang, Nanping Wang, Mingyang Wang, Wenxia Wang, Yaru Wang, Zikun Wang, Shidong Wang, Bei Bei Wang, Yu-Hui Wang, Rui Wang, Yige Wang, Tongxin Wang, Xiaohua Wang, Changjing Wang, Xingjin Wang, Bingjie Wang, Shaoyu Wang, Hui-Hui Wang, Zhenyu Wang, Baoying Wang, Yang-Yang Wang, Shi-Yao Wang, Lifei Wang, Fangfang Wang, Zhimei Wang, Kunpeng Wang, Binglong Wang, Daijun Wang, Qinghang Wang, Zi Wang, Shushu Wang, QingDong Wang, Qing K Wang, Fuhua Wang, Yanni Wang, Jianle Wang, Wenyan Wang, Jinning Wang, Ziqi Wang, Wei-Qi Wang, Yaolou Wang, Haoming Wang, Jian-Wei Wang, Tian Wang, Peixi Wang, Iris X Wang, Tongxia Wang, Mei-Xia Wang, Haiying Wang, Tielin Wang, Hongze Wang, Chung-Hsi Wang, Peiyao Wang, Linli Wang, Guanru Wang, Yuzhong Wang, Yunhan Wang, Jianan Wang, Menglong Wang, Yingxue Wang, Jiayi Wang, Dingxiang Wang, Ting Wang, Fenglin Wang, Jianqun Wang, Ran Wang, Kuan Hong Wang, Liusong Wang, Wen-Der Wang, Yixuan Wang, Feng Wang, Kaicen Wang, Eryao Wang, Yulei Wang, Huaibing Wang, Zhongzhi Wang, Jinrong Wang, Sujie Wang, Xiaozhong Wang, Xiao-Pei Wang, Li-Na Wang, H X Wang, Linjie Wang, Zhaosong Wang, Yafen Wang, Chuan-Wen Wang, Xiaoning Wang, Li-Xin Wang, Silas L Wang, Baocheng Wang, Hongyi Wang, Zhi-Xiao Wang, Shengjie Wang, Zhi-Hao Wang, Yaokun Wang, Shao-Kang Wang, Qunxian Wang, Jianghui Wang, Zhao Wang, Di Wang, Jianzhi Wang, Ruijing Wang, Ling Jie Wang, Qingshi Wang, Jianye Wang, Yuqiang Wang, Kangling Wang, Anxin Wang, Shengli Wang, Zhulin Wang, Hua-Wei Wang, Yiwen Wang, Yang Wang, Hanqi Wang, Changwei Wang, Honglei Wang, Yi Lei Wang, Wenkang Wang, Junjie Wang, Yazhou Wang, Peng-Cheng Wang, Chenzi Wang, Anqi Wang, Yuemiao Wang, Xuelin Wang, Rujie Wang, Dongyan Wang, Yuxue Wang, Wengong Wang, Qigui Wang, Junqing Wang, Ruhan Wang, Xinye Wang, Huihui Wang, Gengsheng Wang, Mark Wang, Zhidong Wang, Mengmeng Wang, Yuwen Wang, Liang Wang, Huaxiang Wang, Fangjun Wang, Huixia Wang, Haijiao Wang, Hong-Hui Wang, Yi-Shan Wang, Yunchao Wang, Junjun Wang, Binghai Wang, Xinguo Wang, Jun-Sing Wang, Lingzhi Wang, Yuexiang Wang, Hong-Gang Wang, Yen-Feng Wang, Xidi Wang, Jiawen Wang, Liangfu Wang, Lifeng Wang, Shihan Wang, Wentian Wang, Sa A Wang, Lee-Kai Wang, Yu-Wei Wang, Zumin Wang, Shau-Chun Wang, Jianjiao Wang, Tian-Tian Wang, Jiantao Wang, Edward Wang, Jianbo Wang, Qingfeng Wang, Wenran Wang, Xiaolin Wang, Fenghua Wang, Rongjia Wang, Shiqiang Wang, Caixia Wang, Guihu Wang, Xindong Wang, Wenxiu Wang, Xueguo Wang, YiLi Wang, Aizhong Wang, Qiqi Wang, Chengcheng Wang, D Wang, L Wang, Jianhua Wang, Qiuling Wang, Shaolian Wang, Wen-Qing Wang, Wenqing Wang, Yuchuan Wang, Guangdi Wang, Yiquan Wang, Huimei Wang, Genghao Wang, Zun Wang, Miranda C Wang, Annette Wang, Chi-Ping Wang, Hanmin Wang, Zhaoxi Wang, Shifeng Wang, Runze Wang, Mangju Wang, Junjiang Wang, Dong D Wang, Xiu-Ping Wang, Haijiu Wang, Linghuan Wang, Yiying Wang, Renqian Wang, Nana Wang, Xiangdong Wang, Shiyin Wang, Chaoyi Wang, Menghan Wang, Shuyue Wang, Yongmei Wang, Nanbu Wang, Lihua Wang, Hongyue Wang, Jianli Wang, Chunli Wang, Minghua Wang, Junkai Wang, Chenguang Wang, Siyue Wang, Jun Wang, Shu-Song Wang, Bingyan Wang, Qingping Wang, Zhong-Yu Wang, Fei-Fei Wang, Jennifer E Wang, Z-Y Wang, Dongxia Wang, Dang Wang, Zi-Hao Wang, Rihua Wang, Jutao Wang, Yanzhe Wang, Guohao Wang, Liming Wang, Yishu Wang, Xuemin Wang, Xianfeng Wang, Zixu Wang, Jingfan Wang, Guang-Jie Wang, Guixue Wang, Jiaojiao Wang, Yaxin Wang, Haibing Wang, Weizhong Wang, Hairong Wang, Hai-Jun Wang, Mingji Wang, Yongrui Wang, Huizhi Wang, Longfei Wang, Chongmin Wang, Jingyang Wang, Zhong-Ping Wang, Huanhuan Wang, Baisong Wang, Xiaohui Wang, Fengyang Wang, Wanliang Wang, Ziqiang Wang, Chuan Wang, Jeffrey Wang, Ying-Zi Wang, Ziwei Wang, Xian Wang, Hanyu Wang, Qiming Wang, Dedong Wang, Fengying Wang, Xiaoya Wang, Zhenhua Wang, Yanchun Wang, Keming Wang, Zi-Yi Wang, Dezhong Wang, Jingying Wang, Shouli Wang, Lan-lan Wang, Weiyu Wang, Yuhuai Wang, Jun Yi Wang, Wenying Wang, Xue-Feng Wang, Xing-Lei Wang, Yuehong Wang, Pengyu Wang, Yihe Wang, Guodong Wang, Weijian Wang, Wu-Wei Wang, Y Wang, Ruonan Wang, Jianbing Wang, Mian Wang, Dennis Qing Wang, Nannan Wang, Zuo Wang, Christine Wang, Ruixin Wang, Yaxiong Wang, Siwei Wang, Yuanzhen Wang, Wen-Chang Wang, Haijing Wang, X Wang, Melissa T Wang, Haixia Wang, Qianghu Wang, Hongsheng Wang, Xiurong Wang, Shaowei Wang, Shuo Wang, Zengtao Wang, Yun-Xing Wang, Songtao Wang, Mei Wang, Mengyun Wang, Qingming Wang, Ke-Feng Wang, Zhihao Wang, Haoqi Wang, X E Wang, Xin-Shang Wang, Dongmei Wang, Lingli Wang, Huai-Zhou Wang, Hua Wang, Kunzheng Wang, Mao-Xin Wang, Jingzhou Wang, Jiaqi Wang, Xingbang Wang, Wence Wang, Yongdi Wang, Xin-Qun Wang, Guoyi Wang, Jian-Guo Wang, Jiafu Wang, Pin Wang, Libo Wang, Junling Wang, J Z Wang, Haozhou Wang, Jing Wang, Hezhi Wang, T Q Wang, Xi-Hong Wang, Yuanfan Wang, Endi Wang, Hua-Qin Wang, Jeremy Wang, Songping Wang, Suyun Wang, Jiqing Wang, Shu-Ling Wang, Jennifer X Wang, Lily Wang, Yin-Hu Wang, Jen-Chywan Wang, Qingqing Wang, Shuangyuan Wang, Haihong Wang, Luyun Wang, Yake Wang, Ya-Nan Wang, Weicheng Wang, Jianxiang Wang, Zihua Wang, Lin Wang, Fu-Sheng Wang, Zongbao Wang, Tong-Hong Wang, Xianze Wang, Ting-Ting Wang, Haibin Wang, Xin-Yue Wang, Zhi-Gang Wang, Ziying Wang, Shukang Wang, Wen-Jun Wang, Delin Wang, Yating Wang, Xuehao Wang, Yefu Wang, Yi-Ning Wang, Cheng-zhang Wang, Jing J Wang, Xinglong Wang, Yanqing Wang, Tongyao Wang, Dongyang Wang, Deqi Wang, Qiao Wang, Alice Wang, Yunzhi Wang, Dayong Wang, Renxi Wang, Yeh-Han Wang, Mingya Wang, Longxiang Wang, Hualin Wang, Hailei Wang, Ao Wang, Wanyu Wang, Jiale Wang, Qiangcheng Wang, Huishan Wang, Yunqiong Wang, Xudong Wang, Xifu Wang, Wen-Xuan Wang, Dao Wen Wang, Zhi-Wei Wang, Xingchen Wang, Yanyang Wang, Yutao Wang, Huizhen Wang, Hu WANG, Y P Wang, Wen Wang, Qingsong Wang, Baofeng Wang, Ruo-Ran Wang, Yaobin Wang, Changliang Wang, Pintian Wang, Dai Wang, Su-Guo Wang, Ruting Wang, Fengzhen Wang, Qinrong Wang, HuiYue Wang, Baosen Wang, Shuhe Wang, Yifei Wang, Jiun-Ling Wang, Junhui Wang, Guangzhi Wang, Qijia Wang, Yushe Wang, Jinlong Wang, Zhouguang Wang, Huiyao Wang, Shuxin Wang, Yingyi Wang, Jing-Yi Wang, Yongxiang Wang, Zhi Wang, Dehao Wang, Yi-sheng Wang, Jiazhi Wang, Yunfei Wang, Mingjin Wang, Yaozhi Wang, Jinyu Wang, Jinmeng Wang, LiLi Wang, Shuai Wang, Yan Wang, Jun Kit Wang, Cui Wang, Zhan Wang, Dong-Jie Wang, Yangyang Wang, Xiangguo Wang, Runuo Wang, Ruimin Wang, Pengpu Wang, Nuan Wang, Guangyan Wang, Xin-Liang Wang, Minxiu Wang, Ruifang Wang, Hui Wang, Hongda Wang, Xiyan Wang, Jinxia Wang, Xinchen Wang, Haihua Wang, Delong Wang, Yayu Wang, Xue-Hua Wang, Xin-Peng Wang, Changqian Wang, Bei Wang, Ya-Han Wang, Chih-Liang Wang, P N Wang, Xiaoqian Wang, Xianshi Wang, Zhiruo Wang, Xueding Wang, Renxiao Wang, Yi-Ming Wang, Tianqi Wang, Ledan Wang, Rongyun Wang, Gan Wang, Qinqin Wang, Yuxiang Wang, Feimiao Wang, Mengyuan Wang, Chaofan Wang, Linshuang Wang, Yanhui Wang, Zhenglong Wang, Zongkui Wang, Zhenwei Wang, Xiyue Wang, Yi Fan Wang, Xiao-Ai Wang, Po-Jen Wang, Xinyang Wang, Linying Wang, Fa-Kai Wang, Yimeng Wang, Dong-Mei Wang, Anli Wang, Hui-Li Wang, Jianqing Wang, Honglun Wang, Wei-Feng Wang, Kaihao Wang, Jialing Wang, Shuren Wang, Cui-Fang Wang, Wenqi Wang, Peilin Wang, Wen-Fei Wang, Guang-Rui Wang, T Wang, Weiqing Wang, Ciyang Wang, Biao Wang, Kaihe Wang, Jieh-Neng Wang, Tony Wang, Yuehu Wang, Zhicheng Wang, Tongtong Wang, Zi Xuan Wang, Yingtai Wang, Xin-Xin Wang, Chu Wang, Tianhao Wang, Shukui Wang, Ching C Wang, Yulin Wang, Chunyang Wang, Yeqi Wang, Yinbo Wang, Kongyan Wang, Weiling Wang, Linxuan Wang, Shengya Wang, Yaqi Wang, Huating Wang, Aiting Wang, Ya Xing Wang, Daoping Wang, Shasha Wang, Wei-Lien Wang, Quanli Wang, Yanru Wang, L M Wang, Bijue Wang, H Wang, Jipeng Wang, Xiaoxia Wang, Shuu-Jiun Wang, Baitao Wang, Haimeng Wang, Chung-Hsing Wang, Weining Wang, M Y Wang, Wenwen Wang, Zhongsu Wang, Xiaochen Wang, Ligang Wang, Shaohsu Wang, Bing Qing Wang, Jiangbin Wang, Yajun Wang, Chunting Wang, Hemei Wang, En-hua Wang, H-Y Wang, Zixi Wang, Wenjing Wang, Haikun Wang, Ruxin Wang, Jianru Wang, Yongqiang Wang, Ouchen Wang, Jianyu Wang, Shen Wang, Yixi Wang, Zhi-Hong Wang, Li Dong Wang, Zhou-Ping Wang, Wen-Yong Wang, Meng-Lan Wang, Xiaojie Wang, Leying Wang, Yi-Zhen Wang, Y Y Wang, Jianlin Wang, Guoqing Wang, Jiani Wang, Guan-song Wang, You Wang, Xiangding Wang, Ke Wang, Wendong Wang, Yue Wang, Zhe Wang, K Wang, Zhuo Wang, Su'e Wang, Cangyu Wang, Erfei Wang, Xiaoming Wang, Aijun Wang, Xiaoye Wang, Jun-Sheng Wang, Wenxiang Wang, Yanjun Wang, Qiangqiang Wang, Yachun Wang, Haitao Wang, Tiancheng Wang, Gangyang Wang, Jianmin Wang, Jiabo Wang, Yijing Wang, Mengzhi Wang, Yinuo Wang, Zhou Wang, Guiying Wang, Xuezheng Wang, Shan Wang, Aoli Wang, Fuqiang Wang, Yawei Wang, Xianxing Wang, Ya-Long Wang, Yuyang Wang, Dong Hao Wang, Y-S Wang, Zelin Wang, Liqun Wang, Cunyi Wang, Qian-Zhu Wang, Yinan Wang, Panfeng Wang, Guangwen Wang, J Q Wang, Guang Wang, Yu-Ping Wang, John Wang, Jiaping Wang, Zhisheng Wang, Xuan-Ren Wang, Xiaowu Wang, Zhengyu Wang, Baowei Wang, Zhijun Wang, Zhong-Hao Wang, Fengzhong Wang, Jin-Da Wang, Zhaoqing Wang, Yuanbo Wang, Haixin Wang, Yaping Wang, Lixiu Wang, Mingxia Wang, Neng Wang, Guozheng Wang, Yan-Feng Wang, Huafei Wang, Yuhan Wang, Xingxing Wang, Wenhe Wang, Xing-Huan Wang, Xiansong Wang, Yishan Wang, Ruming Wang, Ya Qi Wang, Yueying Wang, Chunle Wang, Shihua Wang, W Wang, Hengjun Wang, Meihui Wang, Huanyu Wang, Ruinan Wang, Qiwei Wang, Zhong Wang, Shiyao Wang, Jian-Zhi Wang, Ruimeng Wang, Jinxiang Wang, Jinsong Wang, Bin-Xue Wang, Fuwen Wang, Yiou Wang, Shifa Wang, Yin Wang, Yanzhu Wang, Jia Bin Wang, Siyang Wang, Zhanggui Wang, Yueting Wang, Qingyu Wang, Qianqian Wang, Xiu-Lian Wang, Fengling Wang, Chenxi Wang, Cheng An Wang, Yipeng Wang, Weipeng Wang, Zechen Wang, Shuaiqin Wang, Xueqian Wang, Chan Wang, Guohang Wang, Cai-Yun Wang, Jiang Wang, Huei Wang, Yufeng Wang, Heng Wang, Qing-Liang Wang, Chuang Wang, Xiaofang Wang, Hao-Ching Wang, Junying Wang, Jianwei Wang, Jinhai Wang, Hanchao Wang, Penglai Wang, I-Ching Wang, S L Wang, Tianhu Wang, Sheng-Min Wang, Pan-Pan Wang, Duan Wang, Xuqiao Wang, Minghuan Wang, Wei-Wei Wang, Xiaojian Wang, Shuping Wang, Jinfu Wang, Biqi Wang, Zhenguo Wang, Fangyan Wang, Sainan Wang, Peijuan Wang, Pei-Yu Wang, Yuyan Wang, Fuxin Wang, Ji M Wang, Yange Wang, Yali Wang, Wenhui Wang, Leishen Wang, Lichan Wang, Xianna Wang, Wenbin Wang, Kenan Wang, Chih-Yuan Wang, Yanlei Wang, Ju Wang, Yanliang Wang, Keqing Wang, Bangshing Wang, Dayan Wang, Yongsheng Wang, Dinghui Wang, Zheyue Wang, Xinke Wang, Daqing Wang, Yan Ming Wang, He-Ling Wang, Shengyao Wang, Jiwen Wang, Xizhi Wang, Luxiang Wang, Dandan Wang, RongRong Wang, Heng-Cai Wang, Jindan Wang, Xiaoding Wang, Yumeng Wang, Heling Wang, Xiao-Yun Wang, Meiding Wang, Zhilun Wang, Guo-hong Wang, Na Wang, Yanli Wang, Fubing Wang, Feixiang Wang, Zhiyuan Wang, Yi-Cheng Wang, Zhengwei Wang, Wenyuan Wang, Yu-Ying Wang, Jianqin Wang, Sijia Wang, Chuansen Wang, Huawei Wang, Kaiyan Wang, Qingyuan Wang, Yujia Wang, Lian Wang, Junrui Wang, Chao-Yung Wang, Zehao Wang, Ruixue Wang, Minjun Wang, Jin Wang, Xiaoxiao Wang, Jun-Feng Wang, Binquan Wang, Shuxia Wang, Donggen Wang, Deming Wang, Chenggang Wang, Chuduan Wang, Haichuan Wang, Catherine Ruiyi Wang, Hai-Feng Wang, Anthony Z Wang, Guanghui Wang, Jiahao Wang, Xiaosong Wang, Zijue Wang, Wenbo Wang, M-J Wang, Yu Wang, Yingping Wang, Zhengbing Wang, G Q Wang, Mengjing Wang, Zhendong Wang, Kailu Wang, Jinfeng Wang, Zhiguo Wang, Yusha Wang, Jianmei Wang, Kun Wang, Lihong Wang, Haoxin Wang, Haowei Wang, Ziqing Wang, Aihua Wang, Yuanyong Wang, Sanwang Wang, Doudou Wang, Hao-Yu Wang, Peirong Wang, Wenting Wang, Yibing Wang, He Wang, Jia-Peng Wang, Shixin Wang, En-bo Wang, Dong-Dong Wang, Hualing Wang, Hongyan Wang, Shaoying Wang, Yingjie Wang, Tianqing Wang, Guo-Hua Wang, Yongfei Wang, Lijing Wang, Hongli Wang, Zixian Wang, Niansong Wang, Liangxu Wang, Xinrong Wang, X-T Wang, Zhenning Wang, Dake Wang, Yu-Ting Wang, Zonggui Wang, Daping Wang, Joy Wang, Chenji Wang, Jingmin Wang, Yuyin Wang, Jin-Cheng Wang, Jiangbo Wang, Huiyang Wang, Chi Chiu Wang, He-Cheng Wang, Zhongjing Wang, Weina Wang, Qiaohong Wang, Qintao Wang, Jenny Y Wang, Zheyi Wang, Robert Yl Wang, Zhaotong Wang, Ya Wang, Fangyu Wang, Haobin Wang, Tianyuan Wang, Xinrui Wang, Zhehao Wang, Yihan Wang, Chuan-Jiang Wang, Jianjun Wang, Yongfeng Wang, Gaofu Wang, Ying-Piao Wang, Jingwei Wang, Mengjiao Wang, Chuyao Wang, Yanping Wang, Xinchun Wang, Shu Wang, Guibin Wang, Hong-Ying Wang, Linping Wang, Yugang Wang, Xinru Wang, Fengyun Wang, Heyong Wang, Ziping Wang, Yuegang Wang, Xiangyu Wang, Haoran Wang, Xiaomei Wang, Fang Wang, Lina Wang, Guowen Wang, Liyun Wang, Qingshui Wang, Baoyun Wang, Li-Juan Wang, Tongsong Wang, Jingyun Wang, Huiguo Wang, Zhibo Wang, Lou-Pin Wang, Renjun Wang, Huiting Wang, Junfeng Wang, Zihan Wang, Linhua Wang, Zhiji Wang, Fubao Wang, Eunice S Wang, Xiaojuan Wang, Yuewei Wang, Shuang Wang, Ruey-Yun Wang, Xiaoling Wang, Weihua Wang, Yanggan Wang, Jia Wang, Chaoqun Wang, Xiao-liang Wang, Manli Wang, Yongkang Wang, Huiwen Wang, Ting Chen Wang, Yixian Wang, Xinlin Wang, Shuya Wang, Bochu Wang, Kehao Wang, Sasa Wang, Mengshi Wang, Qiu-Ling Wang, Chengshuo Wang, Mengru Wang, Yiwei Wang, Xueyun Wang, Yijun Wang, Haomin Wang, Meng C Wang, Mengxiao Wang, Huan-You Wang, Jingheng Wang, Carol A Wang, Benjamin H Wang, Penglong Wang, Pei-Wen Wang, Jian-Long Wang, Wang Wang, Jinhui Wang, Yuanqing Wang, Jacob E Wang, Jian-Xiong Wang, Wenyu Wang, Chengze Wang, Hongmei Wang, Fengqiang Wang, Zijun Wang, Shaochun Wang, Qinwen Wang, Ruicheng Wang, Aixian Wang, Yanling Wang, Lu-Lu Wang, Linyuan Wang, Yeming Wang, Ye Wang, Tian-Yi Wang, Zhichao Wang, Dangfeng Wang, Jiucun Wang, Guo-Liang Wang, Guandi Wang, Zhuo-Xin Wang, Aili Wang, Fengliang Wang, Yingzi Wang, Lirong Wang, Xuekai Wang, Wei-En Wang, Jing-Xian Wang, Hesuiyuan Wang, Yuexin Wang, Suzhen Wang, Luping Wang, Xiuyu Wang, Zicheng Wang, Jiliang Wang, Rikang Wang, Xue Wang, Shudan Wang, Chun Wang, Hongxin Wang, Chenglong Wang, Junxiao Wang, Zhiqing Wang, Shawn Wang, Shunran Wang, Tiantian Wang, Youhua Wang, Xiao-Hui Wang, Qing-Yan Wang, Hanying Wang, Qiuping Wang, Yongzhong Wang, Jin-Xia Wang, Xiao-Tong Wang, Shun Wang, Xiaoqun Wang, Ching-Jen Wang, Xin Wang, Hanbin Wang, Yingwen Wang, Jia Bei Wang, Xiaodan Wang, Wenhan Wang, Jia-Yu Wang, Xiaozhi Wang, Xinkun Wang, Jinhao Wang, KeShan Wang, Shengdong Wang, Jinzhu Wang, Lihui Wang, Bicheng Wang, Chao-Jun Wang, Shaoyi Wang, Yajing Wang, Qing-Bin Wang, Feiyan Wang, Geng Wang, Chen Wang, Zhimin Wang, Cenxuan Wang, Wenjun Wang, Chuan-Chao Wang, Zexin Wang, Shu-Huei Wang, Yonggang Wang, Zhaoyu Wang, Xiaochuan Wang, Chuan-Hui Wang, Junshuang Wang, X F Wang, Li-Ting Wang, Chenxin Wang, Qiao-Ping Wang, Jingqi Wang, Xiongjun Wang, Shuang-Shuang Wang, Xu Wang, Houchun Wang, Yaodong Wang, Lujuan Wang, Jilin Wang, Peichang Wang, Keyun Wang, Ruixuan Wang, Zhangying Wang, Lianyong Wang, Dongyu Wang, Xinghui Wang, Binghan Wang, Guanduo Wang, Xian-e Wang, Guimin Wang, Xiaomeng Wang, Yuh-Hwa Wang, Jinru Wang, Mingyu Wang, Binbin Wang, Chaokui Wang, Linhui Wang, Youzhi Wang, Zhenqian Wang, Jialiang Wang, Sufang Wang, Haiyan Wang, Yankun Wang, Yingbo Wang, Zilong Wang, Xiao-Qun Wang, Lin-Fa Wang, Wenhao Wang, P Wang, Rui-Hong Wang, Xiao-jian WANG, Pei Chang Wang, Zhengkun Wang, Vivian Wang, Ying Wang, Zihuan Wang, Peiwen Wang, Chao Wang, Da-Zhi Wang, He-Tong Wang, Mofei Wang, Zezhou Wang, Liyong Wang, Bruce Wang, Hao-Tian Wang, Jin-Juan Wang, Yucheng Wang, Yong-Gang Wang, Saili Wang, Xiuwen Wang, Ruiquan Wang, Xinmei Wang, Zhezhi Wang, Xiao-Jie Wang, H Y Wang, Li-Dong Wang, Duanyang Wang, Kaiting Wang, Yikang Wang, Yichen Wang, Ting-Chen Wang, Meixia Wang, ZhenXue Wang, Juan Wang, Shouling Wang, Lan Wang, Li Chun Wang, Xingxin Wang, Ruibing Wang, Xue-Ying Wang, Bi-Dar Wang, Jiayang Wang, Suxia Wang, Yumin Wang, Qing Jun Wang, Xinbo Wang, Youli Wang, Yi-Ni Wang, Xinran Wang, Lixian Wang, Kan Wang, Ruiming Wang, Qing-Yuan Wang, Kai-Kun Wang, Yaoxian Wang, Qing-Jin Wang, Junmei Wang, Xin Wei Wang, J P Wang, Xufei Wang, Yuqin Wang, Handong Wang, Li-San Wang, Guoling Wang, Wenrui Wang, Zhongwei Wang, Shi-Han Wang, Ruoxi Wang, Huiping Wang, Mu Wang, Weihong Wang, Minzhou Wang, Yakun Wang, Da-Cheng Wang, Pengjie Wang, Qihua Wang, Ji-Nuo Wang, Deshou Wang, Xiaowen Wang, Yaochun Wang, Qihao Wang, Ruiying Wang, Tiange Wang, Xi Wang, Yindan Wang, Lixin Wang, Zhaofeng Wang, Guixin Wang, Erming Wang, Haoyu Wang, Kexin Wang, Yiqiao Wang, Qi-Qi Wang, Shuiyun Wang, Xi-Rui Wang, Cai-Hong Wang, Zhizheng Wang, Mingxun Wang, Liangli Wang, Theodore Wang, Alexander Wang, Huayang Wang, Yinyin Wang, Shuzhong Wang, Tingting Wang, Jiao Wang, Wenxian Wang, Jianghua Wang, Furong Wang, Shijun Wang, Le Wang, Guihua Wang, Xiaokun Wang, Xia Wang, Jiabei Wang, Guoying Wang, Zeyuan Wang, Jue Wang, Jin-E Wang, Jingru Wang, Chun-Li Wang, Xiaole Wang, Ermao Wang, Lanlan Wang, Ye-Ran Wang, Hao Wang, Xv Wang, Shikang Wang, Yufei Wang, Siyi Wang, Xiujuan Wang, Qinyun Wang, Xiangwei Wang, Jian-Hong Wang, David Q-H Wang, Chunjuan Wang, Weiyan Wang, Jia-Liang Wang, Yanxing Wang, Sheri Wang, Chenwei Wang, Haoping Wang, Sheng-Quan Wang, Xiangrong Wang, Xiao-Yi Wang, Huan Wang, Zhitao Wang, Xinyan Wang, J Wang, Kaixi Wang, Huihua Wang, Renwei Wang, Xiaoliang Wang, Xiao-Lin Wang, Tian-Lu Wang, Jiou Wang, Weiqin Wang, Jiamin Wang, Dennis Wang, Ji-Yao Wang, Pingping Wang, Jinyang Wang, Chen-Cen Wang, Chien-Wei Wang, Daolong Wang, Rong-Tsorng Wang, Yuwei Wang, Guo-Ping Wang, Zhentang Wang, F Wang, Xueju Wang, Saisai Wang, Zhehai Wang, Y B Wang, Xiao Wang, Guobing Wang, Kangmei Wang, Chunguo Wang, Longcai Wang, Haina Wang, Chih-Hsien Wang, Yuli Wang, Ling-Ling Wang, Zhangshun Wang, Xue-Lian Wang, Jianxin Wang, Da-Yan Wang, Xianghua Wang, Peng Wang, Yu Qin Wang, Zhao-Jun Wang, Rui-Rui Wang, Xingyue Wang, Man Wang, Daozhong Wang, Tian-Li Wang, Luhui Wang, Gaopin Wang, Mengze Wang, Jizheng Wang, Hong-Yan Wang, Dongying Wang, Wenkai Wang, Stephani Wang, Dan-Dan Wang, Yicheng Wang, Yusheng Wang, Junwen Wang, Gao Wang, Ruo-Nan Wang, Yifan Wang, Jueqiong Wang, Xuewei Wang, Jianning Wang, Yonglun Wang, Shiwen Wang, Lifang Wang, Fuyan Wang, Jian-Bin Wang, Chonglong Wang, Haiwei Wang, Yike Wang, Chunxia Wang, Kaijuan Wang, Minglei Wang, Jingxiao Wang, Luting Wang, David Wang, Ben Wang, Ji-zheng Wang, Yuncong Wang, Lei P Wang, Tingye Wang, Wenke Wang, Ping Wang, Min Wang, Qiang-Sheng Wang, Xuejing Wang, Zhanju Wang, Xixi Wang, Xiaodong Wang, Chaomeng Wang, Yanong Wang, Xinghao Wang, Jiaming Wang, Siyuan Wang, Jiu Wang, Ruizhi Wang, Qing Mei Wang, Wenyi Wang, Yiqing Wang, Cai Ren Wang, Lianchun Wang, Xing-Ping Wang, Xiaoman Wang, Yanjin Wang, Xueqin Wang, Chenliang Wang, Zhenshan Wang, Junhong Wang, Guiping Wang, Xianrong Wang, Xumeng Wang, Dajia Wang, Huang Wang, Huie Wang, Weiwen Wang, Ruiwen Wang, Qing Wang, Haohao Wang, Bao-Long Wang, P Jeremy Wang, Chengqiang Wang, Suli Wang, Lingyan Wang, Chi Wang, Meng Wang, Luwen Wang, Quan Wang, Yan-Jun Wang, Sen Wang, Ruining Wang, Xiaozhen Wang, Zhiping Wang, Xue-Yao Wang, Yuming Wang, Jingjing Wang, Jiazheng Wang, Yunong Wang, Chongze Wang, Rufang Wang, Qiuning Wang, Tiannan Wang, Liqing Wang, Wencheng Wang, Xuefeng Wang, Yongli Wang, Xinwen Wang, Runzhi Wang, Chaojie Wang, Wentao Wang, Zhifeng Wang, Yanan Wang, Mengqi Wang, Limin Wang, Donglin Wang, Shujin Wang, Chengbin Wang, Qiu-Xia Wang, Zhengxuan Wang, Yancun Wang, Yuhuan Wang, Wei Wang, G-W Wang, Bangmao Wang, Kejia Wang, Jinjin Wang, Qifei Wang, Guobin Wang, Chun-Lin Wang, Jing-Shi Wang, Jiheng Wang, Huajing Wang, Yanlin Wang, Chuansheng Wang, Cailian Wang, Beilan Wang, Luofu Wang, Yangpeng Wang, Jieqi Wang, Weilin Wang, Xiaoxuan Wang, Yangyufan Wang, Xiao-Fei Wang, Chen-Ma Wang, Yun Yong Wang, Shizhi Wang, B Wang, Yuling Wang, Yi-Yi Wang, Fanwen Wang, Aiyun Wang, Jian Wang, Chengyu Wang, Jing-Huan Wang, Ning Wang, Yichuan Wang, L F Wang, Chau-Jong Wang, Xin-Yang Wang, Yunzhe Wang, Xuewen Wang, Sheng-Ping Wang, Bi Wang, Qiuting Wang, Yan-Jiang Wang, Dongshi Wang, Yingna Wang, Jingyue Wang, Hongshan Wang, Chunjiong Wang, Hong-Yang Wang, Yingmei Wang, Danfeng Wang, Zhongyi Wang, Teng Wang, Chih-Hao Wang, Mingchao Wang, Yi-Chuan Wang, Chuning Wang, Shihao Wang, Ming-Wei Wang, Menglu Wang, Zhulun Wang, Wuji Wang, Dao-Xin Wang, Han Wang, Jincheng Wang, Thomas T Y Wang, Qingyun Wang, Guoliang Wang, Jihong Wang, Hong-Qin Wang, G Wang, Hsei-Wei Wang, Linfang Wang, Xiao Ling Wang, Ganyu Wang, Zhengdong Wang, Cuizhe Wang, Hongyu Wang, Lijuan Wang, Jingchun Wang, Youzhao Wang, Zijian Wang, Ziheng Wang, Xingyu Wang, Shuning Wang, Shaokun Wang, Zhifu Wang, Xinqi Wang, Jinqiu Wang, ZhongXia Wang, Yanyun Wang, Dadong Wang, Xingjie Wang, Yiting Wang, Zhongli Wang, Junyu Wang, Jianding Wang, Meng-Wei Wang, Yingge Wang, Zhenchang Wang, Qun Wang, Jin-Xing Wang, Lijun Wang, Shuqing Wang, Fu-Yan Wang, Sheng-Nan Wang, Feijie Wang, Qiuyan Wang, Ying-Wei Wang, Shitao Wang, Meng-hong Wang, Zhengyang Wang, Jinghong Wang, Zhiying Wang, Pei Wang, Weixue Wang, Shiyue Wang, Xiaohong Wang, Daiwei Wang, Jinghua Wang, S X Wang, Jian-Yong Wang, Zeying Wang, Can Wang, Kehan Wang, Yunzhang Wang, Jinping Wang, Chenchen Wang, Chun-Ting Wang, Yujiao Wang, Xinxin Wang, Ji Wang, Sui Wang, Wenqiang Wang, Yingwei Wang, Shuzhen Wang, Daixi Wang, Yanming Wang, Lin-Yu Wang, Hongyin Wang, Zhongqun Wang, Er-Jin Wang, Yi Wang, Ziyi Wang, Lianghai Wang, Zhendan Wang, Xiao-Ming Wang, Chengyan Wang, Hui Miao Wang, Jingyi Wang, Ranran Wang, Banghui Wang, Huilun Wang, Ai-Ting Wang, Wenxuan Wang, Yuan-Hung Wang, Zixuan Wang, Hailing Wang, Xuan-Ying Wang, Jiqiu Wang, Yalong Wang, Xiaogang Wang, Shu-qiang Wang, Yun-Jin Wang, Zijie Wang, Tianlin Wang, Mingqiang Wang, Lufang Wang, Jin'e Wang, Xiru Wang, Cuili Wang, GuoYou Wang, Zhizhong Wang, Haifei Wang, Guorong Wang, Xinyue Wang, Pei-Juan Wang, Jiangong Wang, Yingte Wang, Huajin Wang, Ruibo Wang, Kejian Wang, Cheng-Cheng Wang, Xusheng Wang, Shu-Na Wang, Panliang Wang, Mingxi Wang, Shenqi Wang, Zifeng Wang, Chaozhan Wang, Xiuyuan Hugh Wang, Yuping Wang, Xujing Wang, Kai Wang, Hongbing Wang, Sheng-Yang Wang, Jianfei Wang, Hang Wang, Jing-Jing Wang, Weizhi Wang, Jixuan Wang, De-He Wang, P L Wang, Ningjian Wang, Chunyi Wang, Isabel Z Wang, Yong Wang, Yiming Wang, Mingzhi Wang, Jiying Wang, Qian-Wen Wang, Shusen Wang, Xiaoting Wang, Baogui Wang, Mingsong Wang, Zixia Wang, Demin Wang, Shiyuan Wang, Qiuli Wang, C Wang, Dongliang Wang, Weixiao Wang, Yinsheng Wang, Chunmei Wang, Huaili Wang, Xuelian Wang, Yongjun Wang, Zhi-Qin Wang, Jiaying Wang, Yulong Wang, Ren Wang, Jingnan Wang, Qishan Wang, Zeneng Wang, Guangsuo Wang, Chijia Wang, Huiqun Wang, Hongcai Wang, Donghao Wang, Xing-Jin Wang, Zongji Wang, Shenao Wang, Jiaqian Wang, Xiaoying Wang, Yilin Wang, Hangzhou Wang, Wenchao Wang, Jieyu Wang, Li-E Wang, Xuezhen Wang, Liuyang Wang, Zhiqian Wang, Fang-Tao Wang, Qiong Wang, Meng-Meng Wang, Youji Wang, Jiafeng Wang, Xiaojing Wang, William Wang, Junmin Wang, Laijian Wang, Xuexiang Wang, Huiyan Wang, T Y Wang, Zhaofu Wang, Wen-mei Wang, Yalin Wang, Xinshuai Wang, Daqi Wang, Zhen Wang, Shi-Cheng Wang, Anni Wang, Chunhong Wang, Hai-Long Wang, Pan Wang, Charles C N Wang, Pengxiang Wang, Xianzong Wang, Xike Wang, Qianliang Wang, Chunyan Wang, Xuan Wang, Xiaofen Wang, Zhi-Jian Wang, Feng-Sheng Wang, Xiangru Wang, R Wang, Yi-Shu Wang, Jia-Lin Wang, Yonghong Wang, Lintao Wang, Pai Wang, Yanfei Wang, Xuanwen Wang, Lei-Lei Wang, Chenxuan Wang, James Wang, Xinhui Wang, Shengqi Wang, Yueshen Wang, Shan-Shan Wang, Dingting Wang, Zhige Wang, Jingfeng Wang, Yongqing Wang, Chenyang Wang, Ziliang Wang, Bao Wang, Xueyan Wang, Liping Wang, Xingde Wang, Weijun Wang, Sibo Wang, Yaoling Wang, Donghong Wang, Chenyu Wang, Justin Wang, Baolong Wang, Yiqi Wang, Fengyong Wang, Lichao Wang, Yachen Wang, Quanren Wang, Shiyu Wang, Boyu Wang, Aimin Wang, Zhenghui Wang, Hengjiao Wang, Xiaoxin X Wang, Weimin Wang, Mutian Wang, Zhuo-Hui Wang, Xingye Wang, Zou Wang, Yu-Wen Wang, Shaoli Wang, Xin-Ming Wang, Weirong Wang, Kangli Wang, Yaoxing Wang, Xuejie Wang, Qifeng Wang, Xiaoxin Wang, Yinghui Wang, Jianzhang Wang, Tom J Wang, Yaqiong Wang, Zongwei Wang, Yun-Hui Wang, Haiyun Wang, Zhiyou Wang, Lijin Wang, Jifei Wang, Haiyong Wang, Xiao-Xia Wang, Shyi-Gang P Wang, Chih-Yang Wang, Zhixin Wang, Jun-Jun Wang, Tianjing Wang, Zhixia Wang, Chuanhai Wang, Zhijie Wang, Silu Wang, Jianguo Wang, Ming-Hsi Wang, Liling Wang, Yanting Wang, Haolong Wang, Xue-Lei Wang, Ru Wang, Qinglin Wang, Christina Wang, Mimi Wang, Menghui Wang, Wenju Wang, Junhua Wang, S S Wang, Fangyong Wang, Lifen Wang, Zhenbin Wang, Yapeng Wang, Shaoshen Wang, B R Wang, Sugai Wang, Hequn Wang, Songlin Wang, Wenjie Wang, Xiang-Dong Wang, Ting-Hua Wang, Mingliang Wang, Chengniu Wang, Guoxiang Wang, E Wang, Xiaochun Wang, Xueting Wang, Ming-Jie Wang, Zhaojing Wang, Dongxu Wang, Yirui Wang, Jiatao Wang, Jing-Min Wang, Shih-Wei Wang, Zhengchun Wang, Chaoxian Wang, Zehua Wang, Qiyu Wang, Shuye Wang, Baojun Wang, Qing Kenneth Wang, Xichun Wang, Jianliu Wang, Junping Wang, Yudong Wang, Mingzhu Wang, Kangning Wang, Wei-Ting Wang, Hongfang Wang, Chengwen Wang, Changduo Wang, Jinkang Wang, Junya Wang, Fengge Wang, Jianping Wang, Chang Wang, Zhifang Wang, Deli Wang, Linghua Wang, Shitian Wang, Lingling Wang, Zhihua Wang, Jun-Ling Wang, Keyi Wang, Lingbing Wang, Peijia Wang, Ruizhe Wang, X O Wang, Wanyi Wang, Ganggang Wang, Pei-Hua Wang, Kaiyue Wang, Xiaojiao Wang, Xun Wang, Shiyang Wang, Ya-Ping Wang, Yirong Wang, Lixing Wang, Danyang Wang, Xiaotang Wang, Taian Wang, Ming Wang, Xiangcheng Wang, Xuemei Wang, Zhixiong Wang, Mengying Wang, Li-Yong Wang, Xinchao Wang, Jianlong Wang, Jinjie Wang, Nan Wang, Weidong Wang, Mei-Gui Wang, L-S Wang, Wuqing Wang, Z Wang, Ya-Zhou Wang, Xincheng Wang, Jing-Wen Wang, Jinyue Wang, Hongyun Wang, Huaizhi Wang, Yan-Zi Wang, Danling Wang, Dongqin Wang, Hongzhuang Wang, Chung-Teng Wang, Yan-Chun Wang, Shi-Xin Wang, Muxuan Wang, Yujie Wang, Yunbing Wang, Yahui Wang, Zhihong Wang, Xiaoshan Wang, Tienju Wang, Chiou-Miin Wang, Yuqian Wang, Shengyuan Wang, Yumei Wang, Ningyuan Wang, Minjie Wang, Zhenda Wang, Qing-Dong Wang, Horng-Dar Wang, Siqi Wang, Kaihong Wang, Hong-Kai Wang, Meiling Wang, Jiaxing Wang, Xueyi Wang, Zhuozhong Wang, Anlai Wang, Julie Wang, Jin-Bao Wang, Keke Wang, Zhang Wang, Yintao Wang, Yong-Bo Wang, Bing Wang, Dalu Wang, Minxian Wang, Zulong Wang, Gao T Wang, Gang Wang, Sophie H Wang, Xinquan Wang, Yi-Ting Wang, Honglian Wang, Ruyue Wang, Jia-Qiang Wang, Seungwon Wang, Shusheng Wang, Yanbin Wang, Chang-Yun Wang, Le-Xin Wang, Juling Wang, Haohui Wang, Chuanyue Wang, Tianqin Wang, Danqing Wang, Keyan Wang, Yeou-Lih Wang, Qinglu Wang, Sun Wang, Rui-Min Wang, Yong-Tang Wang, Xianwei Wang, Lixia Wang, Tong Wang, Xiaonan Wang, Feida Wang, Jiaxuan Wang, Mingrui Wang, Zixiang Wang, Y Z Wang, Yuliang Wang, Ming-Chih Wang, J J Wang, Huina Wang, Jingang Wang, Jinyun Wang, Min-sheng Wang, Wanyao Wang, Ziqiu Wang, Guo-Quan Wang, Xueping Wang, Qixue Wang, Hechuan Wang, Shang Wang, Chaohan Wang, M H Wang, L Z Wang, Jianhui Wang, Xifeng Wang, Xiaorong Wang, Yinong Wang, Zhixiu Wang, Jiaxi Wang, Jiahui Wang, Xiaofei Wang, Feifei Wang, Kesheng Wang, Rong-Chun Wang, Zhi-Xin Wang, Chaoyu Wang, Yongkuan Wang, Zuoyan Wang, Hsueh-Chun Wang, Xixiang Wang, Guanrou Wang, Songsong Wang, Hongyuan Wang, Yubing Wang, Xuliang Wang, Wen-Ying Wang, Xinglei Wang, Dao-Wen Wang, Yun Wang, Ze Wang, Jiyan Wang, Zai Wang, Guan Wang, Chih-Chun Wang, Yiqin Wang, X S Wang, Hongzhan Wang, Exing Wang, Shu-Jin Wang, Shangyu Wang, Shouzhi Wang, Yunduan Wang, Jiyong Wang, Dongdong Wang, Qingzhong Wang, Zi-Qi Wang, Renyuan Wang, Siyu Wang, Donghui Wang, Ming-Yuan Wang, Juxiang Wang, Muxiao Wang, Fu Wang, Fei Wang, Qiuyu Wang, Ertao Wang, Zhi Xiao Wang, Zunxian Wang, Hui-Nan Wang, Rongping Wang, Won-Jing Wang, Leiming Wang, Pu Wang, Shen-Nien Wang, Xiaona Wang, Meng-Ying Wang, Wen-Jie Wang, Jiaxin Wang, RuNan Wang, Jiemei Wang, Ningli Wang, Zhong-Hui Wang, Hong Wang, Hui-Yu Wang, Ziqian Wang, Xinzhou Wang, Zhoufeng Wang, Weiguang Wang, Zusen Wang, Jiajia Wang, Bin Wang, Shu-Xia Wang, Yu'e Wang, Laidi Wang, Xiao-Li Wang, Lu Wang, Zhugang Wang, Maojie Wang, Ganglin Wang, Xinyu Wang, Junlin Wang, Dong Wang, Yao Wang, Ya-Jie Wang, Zhiwu Wang, DongWei Wang, Hongdan Wang, Yanxia Wang, Maiqiu Wang, Guansong Wang, Qingtong Wang, Yingcheng Wang, Wenjuan Wang, Liying Wang, Xiaolong Wang, Weihao Wang, Qiushi Wang, Yingfei Wang, Haoyang Wang, Li-Li Wang, Yanbing Wang, Yingchun Wang, Guangming Wang, Kaiyuan Wang, Shiqi Wang, Qi-En Wang, Song Wang, Jing-Hao Wang, Lynn Yuning Wang, Zekun Wang, Rui-Ping Wang, Yining E Wang, Yuzhou Wang, Liu Wang, Maochun Wang, Cindy Wang, Qian-Liang Wang, Duo-Ping Wang, Linlin Wang, Taishu Wang, Xiang Wang, Qirui Wang, Baoming Wang, Liting Wang, Jiapan Wang, Lingda Wang, Xietong Wang, Jia-Mei Wang, Liwei Wang, Shaozheng Wang, Q Wang, Timothy C Wang, Mengyue Wang, Xing Wang, Yahong Wang, Yuyong Wang, Yujiong Wang, Guangliang Wang, Ya-Qin Wang, Yezhou Wang, Hongjian Wang, Su-Hua Wang, Qian-fei Wang, Meng-Dan Wang, Yuchen Wang, Hongpin Wang, Pengfei Wang, Ge Wang, Meijun Wang, Yan-Ming Wang, Haichao Wang, Tzung-Dau Wang, Runci Wang, Yan-Yi Wang, Cheng-Jie Wang, Chen-Yu Wang, Cong Wang, Yaxuan Wang, Y H Wang, Yongjie Wang, Yuntai Wang, Ranjing Wang, Yiru Wang, Anxiang Wang, Q Z Wang, Shimiao Wang, Guoping Wang, Junke Wang, Xingyun Wang, Zhengyi Wang, Shi-Qi Wang, Yanfeng Wang, Danxin Wang, Chaodong Wang, Zhiqi Wang, Chunyu Wang, Lijia Wang, Chunlong Wang, Haiping Wang, Qingfa Wang, Yu-Fan Wang, Baihan Wang, Chunxue Wang, Liewei Wang, Xinyi Wang, Fu-Zhen Wang, Qing-Mei Wang, Sheng Wang, Yi-Tao Wang, Dawei Wang, Xiaoyu Wang, Ziling Wang, Zhonglin Wang, Rurong Wang, Qingchun Wang, Qiang Wang, Suiyan Wang, Xu-Hong Wang, Jie Jin Wang, Chenyao Wang, Fei-Yan Wang, Shi Wang, Zhiyong Wang, Jieda Wang, Xiaoqi Wang, Linshu Wang, Ruxuan Wang, Qian Wang, Qianxu Wang, Fangjie Wang, Zhaoxia Wang, Jeremy R Wang, Mingmei Wang, Jingkang Wang, Jen-Chun Wang, Changyuan Wang, Chenglin Wang, Meng-Ru Wang, Tianpeng Wang, Zhongfang Wang, Xuedong Wang, Zhuoying Wang, Bingyu Wang, Xuelai Wang, Weilong Wang, Mengge Wang, Qin Wang, Da-Li Wang, Xuanyi Wang, Hongjuan Wang, Zhi-Hua Wang, Hong-Wei Wang, Yulai Wang, Gongming Wang, Yongni Wang, Mengya Wang, Yadong Wang, Chenghao Wang, Hongbo Wang, Kaiming Wang, Haonan Wang, Guanyun Wang, Yilu Wang, Quanxi Wang, Weiyuan Wang, Xiujun Wang, Liang-Yan Wang, Jianshe Wang, Yingxiong Wang, Cunchuan Wang, Jing-Zhai Wang, Yuelong Wang, Yuqi Wang, Xiaorui Wang, Qianjin Wang, Huijun Wang, Xiaobo Wang, Guoqian Wang, Luhong Wang, Kaining Wang, Chaohui Wang, Yanhong Wang, J-Y Wang, Qi-Bing Wang, Xiaohu Wang, Jiayan Wang, Cui-Shan Wang, Lulu Wang, Yong-Jie Wang, Shixuan Wang, Yuanyuan Wang, Jianying Wang, Haizhen Wang, Shuiliang Wang, Qianbao Wang, Jung-Pan Wang, Rixiang Wang, A Wang, Hanbing Wang, Caiqin Wang, Peigeng Wang, Yuan Wang, Yuzhuo Wang, Yubo Wang, Xianding Wang, Qiaoqi Wang, Cuiling Wang, Ai-Ling Wang, Hailong Wang, Yihao Wang, Lan-Wan Wang, Haihe Wang, S Wang, Sha Wang, Xiaoli Wang, David Q H Wang, Jianfang Wang, Yuting Wang, Jinhuan Wang, Kaixu Wang, Hongwei Wang, Yi-Wen Wang, Yizhe Wang, Shengyu Wang, Yanmei Wang, Huimin Wang, Youjie Wang, Kunhua Wang, Chongjian Wang, Ziyun Wang, Tianhui Wang, Huiying Wang, Yue-Nan Wang, Peiyin Wang, Hongbin Wang, Hong Yi Wang, Xinjun Wang, Yian Wang, Liyi Wang, Yunce Wang, Yi-Xuan Wang, Yitao Wang, Jiali Wang, Junqin Wang, Yuebing Wang, Yiping Wang, Yunpeng Wang, Yuxing Wang, Shuqi Wang, Ziyu Wang, Hongjie Wang, Xiaoyan Wang, Lianshui Wang, Xiaolu Wang, Wenya Wang, Fan Wang, Jinhua Wang, Sidan Wang, Lixiang Wang, Y L Wang, Xue-Rui Wang, Kai-Wen Wang, Zhongyu Wang, Xiaoyang Wang, Hongyang Wang, Rencheng Wang, Yinxiong Wang, Yuanli Wang, Zhuqing Wang, Y-H Wang, Yuhui Wang, Xitian Wang, Weizhen Wang, Qi Wang, Qiyuan Wang, Changlong Wang, Yatao Wang, Tengfei Wang, Yehan Wang
articles
Jun Teng, Chongwei Duan, Xinyi Zhang +9 more · 2025 · Journal of dairy science · added 2026-04-24
Cattle body size measurements constitute the conformation traits that facilitate their production, fertility, and longevity status. Prioritizing functional variants and causal genes of conformation tr Show more
Cattle body size measurements constitute the conformation traits that facilitate their production, fertility, and longevity status. Prioritizing functional variants and causal genes of conformation traits is essential for understanding their genetic basis. In this study, we conducted single-trait and multitrait GWAS for 20 body conformation traits using imputed sequence data in 7,674 Chinese Holstein individuals and identified 27 QTL regions. Leveraging these QTL regions, we performed multitrait Bayesian fine-mapping to identify 30 independent credible sets of putative causal variants. Incorporating GWAS and cis-acting expression QTL data, Mendelian randomization was used to infer 153 putative causal gene-trait relationships. The previously reported genes, such as CCND2, TMTC2, and NRG3, were confirmed in our study. Of note, several novel candidate causal genes were also identified, such as C1R, RIMS1, SERPINB8, NETO2, TTYH3, TTC3, ANAPC4, and PSMD13. Our results provide new insights into the regulatory mechanisms of body conformation traits in cattle. Show less
no PDF DOI: 10.3168/jds.2025-26361
ANAPC4
Zhihao Wang, Zhengsheng Wu · 2025 · Frontiers in immunology · Frontiers · added 2026-04-24
Lung squamous cell carcinoma (LUSC) is a leading cause of cancer-related mortality. Although immunotherapy has recently demonstrated clinical benefits, the biological roles of immune-related genes (IR Show more
Lung squamous cell carcinoma (LUSC) is a leading cause of cancer-related mortality. Although immunotherapy has recently demonstrated clinical benefits, the biological roles of immune-related genes (IRGs) in LUSC remain insufficiently understood. In this study, transcriptomic and clinical data from 493 LUSC patients were obtained from The Cancer Genome Atlas (TCGA). IRGs were identified through weighted gene co-expression network analysis, followed by univariate Cox regression and least absolute shrinkage and selection operator (LASSO) regression to screen for prognostic genes and establish a risk prediction model. The model's predictive performance was validated, and the immune landscape associated with distinct risk subgroups was systematically characterized. Expression patterns and clinical significance of the signature genes were further investigated using bioinformatics analysis, quantitative real-time PCR, Western blotting, and immunohistochemistry. A total of 55 differentially expressed IRGs were identified, among which 8 genes ( This study establishes a novel IRGs-based prognostic signature with potential utility for risk stratification and individualized immunotherapeutic strategies in LUSC. Furthermore, it also provides valuable insights into the role of Show less
📄 PDF DOI: 10.3389/fimmu.2025.1724319
ANGPTL4
Anyu Zeng, Hongmin Chen, Tianqi Luo +13 more · 2025 · Molecular cancer · BioMed Central · added 2026-04-24
Osteosarcoma demonstrates limited responsiveness to PD-1 blockade, largely due to its immunosuppressive tumor microenvironment (TME). The specific mechanisms by which cancer-associated fibroblasts (CA Show more
Osteosarcoma demonstrates limited responsiveness to PD-1 blockade, largely due to its immunosuppressive tumor microenvironment (TME). The specific mechanisms by which cancer-associated fibroblasts (CAFs) contribute to immunosuppression in osteosarcoma are not fully understood. We performed single-cell RNA sequencing (scRNA-seq) on osteosarcoma tissues from patients treated with neoadjuvant chemotherapy and anti-PD-1 therapy to investigate the tumor microenvironment. Cellular composition, gene expression programs, and signaling pathways were analyzed. Functional assays, pull-down and PLA-flow binding validation, and in vivo mouse models were used to dissect the mechanisms by which CAF-derived factors influence CD8⁺ T cell function and contribute to immunotherapy response. We identified a subpopulation of CD36⁺ CAFs, characterized by adaptive uptake of oxidized low-density lipoprotein (OxLDL) and activation of the PPARG-FABP4 axis. This metabolic program promoted ANGPTL4 secretion, which bound integrin on CD8⁺ T cells and activated the JAK2-STAT3 pathway, leading to T cell exhaustion and impaired effector function. In vivo, administration of VitE effectively scavenged OxLDL, reprogrammed the TME, enhanced CD8⁺ T cell infiltration, and synergized with PD-1 blockade to improve tumor control. CD36⁺ CAFs drive immunosuppressive metabolic reprogramming via the OxLDL-PPARG-ANGPTL4 axis, promoting CD8⁺ T cell exhaustion and resistance to immunotherapy in osteosarcoma. Targeting this pathway with VitE alleviated CAF-mediated immune suppression and enhanced PD-1 blockade responses in preclinical models, providing a rationale for metabolism-based combinatorial strategies in osteosarcoma. Show less
📄 PDF DOI: 10.1186/s12943-025-02516-2
ANGPTL4
DuJiang Yang, Jiexiang Yang, GuoYou Wang · 2025 · Journal of cellular physiology · Wiley · added 2026-04-24
In their recent study, Zeng et al. (2025) employed single-cell RNA sequencing to delineate the landscape of spinal cord injury (SCI), highlighting a previously underappreciated communicative role for Show more
In their recent study, Zeng et al. (2025) employed single-cell RNA sequencing to delineate the landscape of spinal cord injury (SCI), highlighting a previously underappreciated communicative role for endothelial tip cells in engaging astrocytes and macrophages. While their work provides a valuable resource and generates compelling hypotheses, it also opens several critical avenues that demand immediate scrutiny. This Letter offers a prospective outlook and a critical examination of their findings. We argue that the computationally predicted paracrine networks, such as the Angptl4-Sdc4 axis identified by the authors, require rigorous in vivo functional validation to establish causality. Furthermore, the current snapshot data lack the temporal and spatial resolution necessary to decipher the dynamics of these interactions. Most importantly, we explore the therapeutic dilemma of targeting tip cells-a strategy that must delicately balance their detrimental signaling roles against their indispensable function in revascularization. Addressing these challenges is paramount to transforming these descriptive insights into mechanistic understanding and viable therapeutic strategies for SCI. PRE-REGISTERED CLINICAL TRIAL NUMBER: Not applicable. Show less
no PDF DOI: 10.1002/jcp.70117
ANGPTL4
Kuangyang Chen, Yifeng Pan, Yaqiong Wang +8 more · 2025 · Journal of translational medicine · BioMed Central · added 2026-04-24
Atherosclerosis, a progressive inflammatory disease and the leading cause of cardiovascular disease (CVD), remains a global health burden due to the lack of effective early therapeutic interventions. Show more
Atherosclerosis, a progressive inflammatory disease and the leading cause of cardiovascular disease (CVD), remains a global health burden due to the lack of effective early therapeutic interventions. Although growing evidence highlights the involvement of plasma proteins in atherogenesis, their causal contributions to disease pathogenesis are poorly understood. To address this gap, we conducted a proteome-wide Mendelian randomization (MR) analysis using cis-pQTLs (cis-protein quantitative trait loci) from the deCODE and UKB-PPP cohorts (~90,000 individuals) as instrumental variables. We integrated colocalization analysis, summary-data-based MR (SMR), and HEIDI tests to systematically prioritize causal plasma proteins. Key findings were replicated in the CARDIOGRAMplusC4D (coronary artery disease, CAD) and FinnGen (CVD) cohorts. Functional validation was performed through phenome-wide association studies (PheWAS), single-cell transcriptomics, histological staining, and ELISA assays to characterize protein expression patterns in specific cell types and tissues. Among 2,711 plasma proteins analyzed, 28 showed strong genetic associations with atherosclerosis. Of these, five proteins (ADK, ANGPTL4, CD4, MGAT1, SYT11) met strict validation criteria through colocalization (posterior probability of colocalization, PP.H4 > 0.8) and SMR. Subsequent replication using MR and PheWAS further confirmed the causal roles of ADK, CALB2, and COMT in CAD and other CVD outcomes. Notably, CALB2 was specifically enriched in mast cells within atherosclerotic plaques and adipose tissue, and plasma levels were significantly elevated in patients with severe carotid artery stenosis (CAS). This study identifies 28 novel therapeutic targets for atherosclerosis using a rigorous multi-omics approach. Our findings establish CALB2 as a promising biomarker and therapeutic target, particularly in severe CAS, by linking genetic evidence to cell-type-specific expression and clinical phenotypes. These insights pave the way for precision medicine approaches in the prevention and treatment of CVD. The online version contains supplementary material available at 10.1186/s12967-025-07269-6. Show less
📄 PDF DOI: 10.1186/s12967-025-07269-6
ANGPTL4
Linda A Cernichiaro-Espinosa, Gustavo A Miranda-Carboni, David J Taylor-Gonzalez +10 more · 2025 · iScience · Elsevier · added 2026-04-24
In uveal melanoma (UM), the most common primary intraocular tumor, up to half of patients develop fatal metastases despite high local tumor control. Effective treatments for genetically high-risk tumo Show more
In uveal melanoma (UM), the most common primary intraocular tumor, up to half of patients develop fatal metastases despite high local tumor control. Effective treatments for genetically high-risk tumors remain limited, largely due to challenges posed by cancer stem cells (CSCs) and the tumor microenvironment (TME), which sustain tumor progression and resistance. Our study evaluated stemness properties in UM tumor cells, focusing on Show less
📄 PDF DOI: 10.1016/j.isci.2025.113744
ANGPTL4
Tao Geng, Shiyu Qi, Xuan Cao +12 more · 2025 · Frontiers in cardiovascular medicine · Frontiers · added 2026-04-24
Atrial fibrosis serves as a key pathological basis for atrial fibrillation, significantly elevating the risk of cardiovascular events. However, its molecular mechanisms remain incompletely understood. Show more
Atrial fibrosis serves as a key pathological basis for atrial fibrillation, significantly elevating the risk of cardiovascular events. However, its molecular mechanisms remain incompletely understood. N⁶-methyladenosine (m6A) modifications have been proven to involve in the pathological processes of cardiovascular diseases, yet its role in atrial fibrosis remains unclear. m6A plays an important role in disease pathogenesis via mRNA modification. This study aimed to define the role of m6A modifications in the fibrotic atria of rats with chronic intermittent hypoxia (CIH). A CIH model was established using rats living in an intermittent hypoxia simulation chamber filled with oxygen and nitrogen. Myocardial function and atrial fibrosis were examined by echocardiography, electrophysiology, and histopathology. Methylated RNA immunoprecipitation sequencing (MeRIP-Seq) and mRNA sequencing (mRNA-Seq) were performed on atria from control and CIH rats to identify differential m6A methylated genes and transcripts and further analyze their coexistence. Functional enrichment of the conjoint genes was analyzed using Gene Ontology and Kyoto Encyclopedia of Genes and Genomes assays. m6A distribution of the conjoint gene ANGPTL4 (angiopoietin like 4) was also observed. ANGPTL4 and m6A-related gene expression levels were determined by quantitative real-time polymerase chain reaction. CIH led to electrical conduction dysfunction and abnormal expression of fibrosis-associated proteins, indicating successful atrial fibrosis. Conjoint analysis identified 10 genes with upregulated m6A peaks and transcripts and 24 genes with downregulated m6A peaks and transcripts. These genes were functionally enriched in the calcium ion transport-related and fibrosis pathways (extracellular matrix receptor interaction). The m6A modification level of ANGPTL4 mRNA and the expression of four m6A regulatory enzymes were significantly different between control and CIH rats. Our results revealed that m6A modification plays a crucial role in atrial fibrosis and may provide new therapeutic strategies for this disease. Show less
📄 PDF DOI: 10.3389/fcvm.2025.1670859
ANGPTL4
Mina Ali, Martin Steen Mortensen, Ole Bæk +11 more · 2025 · Metabolites · MDPI · added 2026-04-24
📄 PDF DOI: 10.3390/metabo15100670
ANGPTL4
Wenxue Yao, Qianqian Sun, Ruize Wu +7 more · 2025 · Environmental pollution (Barking, Essex : 1987) · Elsevier · added 2026-04-24
Nickel exposure increases the risk of lung cancer; however, the mechanisms underlying nickel-induced oncogenic cell death remain unclear. While ferroptosis is linked to lung cancer, its role in nickel Show more
Nickel exposure increases the risk of lung cancer; however, the mechanisms underlying nickel-induced oncogenic cell death remain unclear. While ferroptosis is linked to lung cancer, its role in nickel-induced malignant transformation is not well understood. We simulated long-term exposure of human bronchial epithelial cells (Beas-2B cells) to nickel-refining fumes (NiRF) from a smelter and found that NiRF exposure induced their malignant transformation. Ferroptosis was inhibited in these transformed cells (2B-NiRF cells), a phenomenon also observed in NiRF-exposed mouse lung tissue. Treatment of 2B-NiRF cells with ferroptosis inducers and inhibitors indicated that ferroptosis suppresses their malignant phenotype. Transcriptome analysis of 2B-NiRF cells revealed enrichment in hypoxia and HIF-1 signaling pathways. Mechanistically, the NiRF-induced hypoxic microenvironment inactivates prolyl hydroxylase domain protein 1 (PHD1), stabilizing hypoxia-inducible factor-1α (HIF-1α), which coordinates the transcriptional program to maintain 2B-NiRF cells in a ferroptosis-resistant state. Overexpression of PHD1 inhibits HIF-1α and its downstream angiopoietin-like protein 4 (ANGPTL4)/janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway, thereby restoring sensitivity to ferroptosis in 2B-NiRF cells; knockdown of ANGPTL4 similarly modulates sensitivity to ferroptosis. This underscores the crucial role of the PHD1/HIF-1α/ANGPTL4/JAK2/STAT3 axis in ferroptosis-mediated NiRF-induced malignant transformation. The NiRF-exposed mouse model further confirms that in vivo expression of the PHD1/HIF-1α/ANGPTL4/JAK2/STAT3 axis is dysregulated. In conclusion, this study reveals a novel regulatory cascade in which NiRF inhibits cellular ferroptosis via the PHD1/HIF-1α/ANGPTL4/JAK2/STAT3 axis, thereby inducing malignant transformation of cells, providing potential targets for occupational lung cancer risk management against ferroptosis. Show less
no PDF DOI: 10.1016/j.envpol.2025.127205
ANGPTL4
Lu-Xi Zou, Zhi-Li Hou, Chen-Huan Qian +2 more · 2025 · Annals of medicine · Taylor & Francis · added 2026-04-24
Diabetic kidney disease (DKD) is a common and serious complication in patients with diabetes mellitus (DM). This study was aimed to reveal the validity of seven emerging novel biomarkers of angiopoiet Show more
Diabetic kidney disease (DKD) is a common and serious complication in patients with diabetes mellitus (DM). This study was aimed to reveal the validity of seven emerging novel biomarkers of angiopoietin-like-4 (ANGPTL4), neutrophil gelatinase-associated lipocalin (NGAL), monocyte chemoattractant protein-1 (MCP-1), growth differentiation factor-15 (GDF15), fibroblast growth factor-23 (FGF23), n-terminal osteopontin (ntOPN) and pyruvate kinase muscle isozyme M2 (PKM2) in detecting DM patients at high risk of DKD and establish prediction models for DKD onset in DM patients. This was a cross-sectional study of 348 adult patients with Type 1 DM for at least 5 years, or Type 2 DM, followed by a prospective observational cohort of 141 adult DM patients without renal involvement at baseline and follow-up for at least 2 years. We performed logistic regression analysis to analyze the relationship between the variables and the risk of DKD occurrence, and receiver operator characteristic (ROC) analysis to assess the predictive ability of multi-biomarker panels for DKD onset. In the cross-sectional cohort, the seven urinary biomarkers were all elevated in DKD patients, of which the high levels of urinary ntOPN, GDF15, NGAL, MCP-1 and FGF23 significantly increased the risk of DKD diagnosis; the urinary MCP-1 alone performed best in DKD detection with the largest area under the ROC curve (AUC). In the prospective cohort, the high levels of urinary GDF15, MCP-1, ANGPTL4 and FGF23 significantly increased the risk of DKD development, and the model constructed based on the above four biomarkers had the largest AUC (0.873) for predicting the 2-year risk of DKD occurrence. Our study demonstrated that the four-biomarker model performed the best in predicting DKD, which could provide more accurate tools for DKD risk prediction, thereby improving the prognosis in DM patients. Show less
📄 PDF DOI: 10.1080/07853890.2025.2562996
ANGPTL4
Lijun Xu, Yujiao Wang, Daojun Xie · 2025 · Frontiers in genetics · Frontiers · added 2026-04-24
Angiogenesis is a critical pathological process in vascular dementia (VD), yet current therapeutic strategies targeting this mechanism remain limited. Identifying novel molecular pathways involved in Show more
Angiogenesis is a critical pathological process in vascular dementia (VD), yet current therapeutic strategies targeting this mechanism remain limited. Identifying novel molecular pathways involved in angiogenesis holds significant promise for advancing both diagnostic and therapeutic approaches for VD. We first applied weighted gene coexpression network analysis (WGCNA) and differentially expressed gene (DEG) analysis, combined with phenotypic gene database mining, to identify angiogenesis-associated genes in VD. We then used the Least Absolute Shrinkage and Selection Operator (LASSO) regression to select key diagnostic genes. The diagnostic efficacy of these genes was evaluated using receiver operating characteristic (ROC) curve analysis, while their association with immune cell infiltration was assessed via xCell immunoinfiltration. Using single-nucleus RNA sequencing (snRNA-seq), we determined the cellular distribution of key genes and applied Gene Set Enrichment Analysis (GSEA) to analyze functional pathways in the differentially expressed cell clusters. Finally, we validated gene expression changes in the hippocampus of bilateral common carotid artery occlusion (BCCAO)-induced VD rats using quantitative polymerase chain reaction (qPCR) and Western blot (WB). Ultimately, we screened five key genes, namely, These five key genes might be used as angiogenesis diagnostic genes for VD and might be novel potential targets for diagnosis, treatment, and prevention. Show less
📄 PDF DOI: 10.3389/fgene.2025.1646991
ANGPTL4
Xiuli Han, He Li, Yu Sun +1 more · 2025 · European journal of medical research · BioMed Central · added 2026-04-24
This study investigates the effect of angiopoietin-like 4 (ANGPTL4) on allergic rhinitis (AR) and explores the underlying mechanisms. A mouse model of AR was generated through ovalbumin (OVA) challeng Show more
This study investigates the effect of angiopoietin-like 4 (ANGPTL4) on allergic rhinitis (AR) and explores the underlying mechanisms. A mouse model of AR was generated through ovalbumin (OVA) challenge. The numbers of nasal rubbing and sneezing were counted and scored. Histological staining was conducted to analyze pathological alterations and inflammation in the mouse nasal mucosa. Inflammatory cytokines in serum and nasal lavage fluid (NALF) samples were analyzed using ELISA kits. Populations of regulatory T cells (Tregs) and Th17 cells in NALF or lymph nodes were analyzed using flow cytometry. Mice with AR were administered short hairpin (sh) RNAs targeting ANGPTL4. The effect of Notch pathway in AR severity was analyzed by gain- and loss-of-function assays. The consistent OVA challenge led to significant AR-like symptoms in mice, along with increased Notch signaling activation. Inhibiting this pathway using γ-secretase inhibitor (DAPT) markedly reduced the AR scores and alleviated inflammatory infiltration by improving Treg/Th17 cell balance. ANGPTL4 silencing significantly mitigated AR-related symptoms, Treg/Th17 cell imbalance, and inflammatory cascades in mice by inactivating the Notch signaling pathway. However, these alleviating effects of ANGPTL4 silencing on mice were negated by the administration of valproic acid, an agonist of the Notch signaling. This paper provides evidence that the ANGPTL4 knockdown shows significant therapeutic effects on AR by improving the Treg/Th17 cell balancing, effects achieved, at least in part, by blocking the Notch signaling pathway. Show less
📄 PDF DOI: 10.1186/s40001-025-03049-6
ANGPTL4
Wanshi Li, Weiwei Pei, Yiwei Wang +16 more · 2025 · British journal of cancer · Nature · added 2026-04-24
In recent years, there has been a steady increase in professionals engaged in radioactive work. The biological impacts of long-term exposure to low dose-rate radiation remain elusive, as there is a de Show more
In recent years, there has been a steady increase in professionals engaged in radioactive work. The biological impacts of long-term exposure to low dose-rate radiation remain elusive, as there is a dearth of systematic research in this field. BEAS-2B cells were used to establish a cell model with continuous passaging after radiation exposure, which was subsequently subjected to in vivo tumorigenesis assays and in vitro malignant phenotype experiments. By scRNA-seq, we conducted copy number variation analysis, cell trajectory analysis, and cell communication analysis. Furthermore, we used FACS, molecular docking, multiplex immunohistochemistry, qRT-PCR, and co-immunoprecipitation to validate and further explore the molecular mechanisms driving tumor evolution. Long-term low dose-rate exposure is associated with a higher degree of malignancy, as evidenced by the induction of more CNV and EMT events, as well as the delayed activation of DNA repair pathways, which trigger increased genomic instability. The long-term low dose-rate specific ligand-receptor pair, ANGPTL4-SDC4, enhances cell malignancy by promoting angiogenesis in newly formed lung tumor cells. This study not only provides the first evidence and mechanistic explanation that long-term low dose-rate radiation leads to increased cellular malignancy but also offers valuable theoretical insights into the dynamic processes of early tumor evolution in lung cancer within the realm of tumor biology. Show less
no PDF DOI: 10.1038/s41416-025-03128-9
ANGPTL4
Xiaolin Zeng, Yuni Long, Gang Li +6 more · 2025 · Journal of cellular physiology · Wiley · added 2026-04-24
Excessive inflammation is a capital cause of scar formation and inflammation microenvironment that result in challenge of axonal regeneration after spinal cord injury (SCI). Macrophages and astrocytes Show more
Excessive inflammation is a capital cause of scar formation and inflammation microenvironment that result in challenge of axonal regeneration after spinal cord injury (SCI). Macrophages and astrocytes play important roles in the inflammatory response. Tip cells, a critical endothelial sub-population, play pivotal roles in post-injury vascular regeneration. Nevertheless, their characteristics in SCI remain poorly documented. This study based on single cell RNA sequencing (scRNA-seq) and in vitro experiment, investigates the effects of tip cells on astrocytes and macrophages. For astrocytes, tip cells can recruit astrocytes to migrant, contribute to the formation of fence-like structure of astrocytes, finally inhibit the diffusion of inflammation via the Angptl4-Sdc4 ligand-receptor pathway. For macrophages, similarly through the Angptl4-Sdc4 ligand-receptor pathway, tip cells can promote macrophages to polarize more toward the M2 phenotype and inhibit their polarization toward M1 phenotype, thus alleviate the inflammatory response. Tip cells after SCI exhibit conserved ribosomal protein expression, implicating ribosome-dependent signaling in their function. These finding highlight the critical role of tip cells in microenvironment after SCI, offering a potential treatment target for SCI. Show less
no PDF DOI: 10.1002/jcp.70088
ANGPTL4
James Yarmolinsky, Evelyn Lau, Fotios Koskeridis +4 more · 2025 · Arteriosclerosis, thrombosis, and vascular biology · added 2026-04-24
Coronary artery disease (CAD) and cancer are 2 leading global causes of mortality, with shared modifiable risk factors, yet the genetic and molecular mechanisms underlying their comorbidity remain poo Show more
Coronary artery disease (CAD) and cancer are 2 leading global causes of mortality, with shared modifiable risk factors, yet the genetic and molecular mechanisms underlying their comorbidity remain poorly understood. We performed a genome-wide pleiotropy analysis to identify shared genetic mechanisms across CAD and 4 common cancers that share modifiable risk factors with CAD (breast, colorectal, lung, prostate). Using genome-wide pleiotropy and colocalization analysis, we identified 60 colocalized susceptibility loci shared by CAD and site-specific cancer, of which 43 are novel, including loci at Our findings highlight shared and opposing genetic loci between CAD and cancer and provide insight into molecular intermediates mediating joint disease risk. Importantly, they indicate potential drug repurposing opportunities for dual CAD and cancer prevention while highlighting possible adverse and divergent effects of existing medications across both conditions. Show less
📄 PDF DOI: 10.1161/ATVBAHA.125.322433
ANGPTL4
Xiujin Shen, Haibing Wang, Chunhua Weng +7 more · 2025 · Kidney international · Elsevier · added 2026-04-24
Angiopoietin-like 4 (Angptl4) is a secreted protein that participates in multiple biological processes. Our previous study on the effect of Angptl4 in minimal change disease (MCD) unexpectedly indicat Show more
Angiopoietin-like 4 (Angptl4) is a secreted protein that participates in multiple biological processes. Our previous study on the effect of Angptl4 in minimal change disease (MCD) unexpectedly indicated a close correlation between Angptl4 and kidney function, especially in MCD patients combined with AKI, implying a possible function of Angptl4 in AKI. However, the role and molecular mechanism of Angptl4 in AKI are undetermined. Biopsy tissue and serum of patients with AKI were analyzed by ELISA and immunohistochemistry to evaluate ANGPTL4 expression and its correlation with kidney function. For in vitro study, ANGPTL4 overexpressed and knocked down HK-2 cells were used to determine the effect of ANGPTL4 on cell pyroptosis. For in vivo study, Angptl4 global and conditional knockout mice were generated to study AKI using cisplatin- or ischemia/reperfusion-induced AKI mouse models. Additionally, we used various experimental approaches to investigate how ANGPTL4 induces tubular cell injury via interaction with integrin β. Angptl4 was up regulated in kidney tubular epithelial cells of multiple AKI models and correlated with kidney function. ANGPTL4 aggravated tumor suppressor GSDME-dependent cell pyroptosis in vitro. In genetic mice, overexpression of Angptl4 worsened kidney function, inflammation, and cell pyroptosis, whereas ablation of Angptl4 attenuated kidney injury in AKI. Mechanistically, ANGPTL4 interacted with integrin β5 and activated focal adhesion kinase (FAK), promoting kidney tubular pyroptosis through the caspase 3/GSDME signaling pathway. Inhibition of integrin β5 or FAK alleviated kidney tubular pyroptosis and kidney dysfunction. Moreover, ANGPTL4 promoted the secretion of cytokines MCP-1 and RANTES by kidney tubular epithelial cells, enhancing macrophage recruitment. Our results reveal that Angptl4 triggers pyroptosis and worsened kidney injury in AKI and offers a potential target for the diagnosis and treatment of AKI. Show less
no PDF DOI: 10.1016/j.kint.2025.07.025
ANGPTL4
Ying Tao, Sheng Shen, Zijun Gong +8 more · 2025 · Cell cycle (Georgetown, Tex.) · Taylor & Francis · added 2026-04-24
Gallbladder cancer (GBC) is a biliary tract cancer with a poor prognosis. Consistent evidence suggests that fasting has extensive antitumor effects in various cancers and influences levels of poly (rC Show more
Gallbladder cancer (GBC) is a biliary tract cancer with a poor prognosis. Consistent evidence suggests that fasting has extensive antitumor effects in various cancers and influences levels of poly (rC)-binding protein 2 (PCBP2). However, whether fasting and PCBP2 are involved in GBC remains unknown. We assessed the expression of PCBP2 in GBC tumor tissues and cells. Knockdown and overexpression of PCBP2, combined with in vitro and in vivo assays using fasting mimic medium or diets, were conducted to provide functional significance. The effect of PCBP2 on glycolysis was assessed by glucose uptake, lactate production, oxygen consumption rate, and limiting glycolytic-associated enzymes (PDK1, PKM2, and HK-2). We found that fasting could inhibit glycolysis and cell migration/invasion in GBC cells and that fasting mimic diets could significantly inhibit GBC cell proliferation in a mouse xenograft model. PBCP2 was upregulated in GBC tumor tissues and cells. Moreover, PCBP2 is a key downstream target of fasting, and fasting decreases PCBP2 expression in GBC cells. PCBP2 knockdown inhibits GBC cell proliferation, migration/invasion, and glycolysis, whereas PCBP2 overexpression has the opposite effect. Through co-immunoprecipitation, we identified a physical connection between PCBP2 and the angiopoietin-like protein ANGPTL4. PCBP2 can negatively regulate the expression of ANGPTL4. Hence, fasting inhibits cell proliferation, migration/invasion, and glycolysis through PCBP2/ANGPTL4 signaling. We conclude that PCBP2 is a target of fasting and is involved in cell migration/invasion and glycolysis through the negative regulation of ANGPTL4 in GBC. PCBP2 represents a potential therapeutic target for GBC. Show less
📄 PDF DOI: 10.1080/15384101.2025.2540137
ANGPTL4
Zhixian Lin, Jinmeng Wang, Yixin Ma +4 more · 2025 · Cancers · MDPI · added 2026-04-24
📄 PDF DOI: 10.3390/cancers17142402
ANGPTL4
Chengcai Kong, Rong Li, Xiaoying Wang +5 more · 2025 · Ecotoxicology and environmental safety · Elsevier · added 2026-04-24
The etiology of spontaneous abortion (SA) is complex, and the underlying mechanisms remain largely elusive. Environmental toxins have been implicated in the increased occurrence of SA. However, the as Show more
The etiology of spontaneous abortion (SA) is complex, and the underlying mechanisms remain largely elusive. Environmental toxins have been implicated in the increased occurrence of SA. However, the association between aminomethylphosphonic acid (AMPA) exposure and SA has not yet been established. We found that AMPA, along with the lactate were significantly elevated in villous tissues from SA patients compared to normal controls, with a robust positive correlation between AMPA and lactate concentrations. More importantly, AMPA exposure induced SA in C57BL/6 mice probably through the dysfunctions of human trophoblast cell. Further studies indicated that the L-lactate production which can be induced by AMPA via PPARγ/ANGPTL4 pathway caused similar defects of human trophoblast cells. A global elevation of protein lactylation has been detected in the villous tissues from SA patients as well as AMPA or lactate treated human trophoblast cells. Pan-Kla antibody coimmunoprecipitation coupled with mass spectrometry of AMPA or lactate treated human trophoblast cells revealed JunB, which was reduced in the placenta villus from SA patients and AMPA/lactate treated human trophoblast cells, could be lactylated at lysine (K) 36. JunB K36R mutation abolished JunB lactylation and ameliorated AMPA induced JunB loss via ubiquitination in human trophoblast cells. In comparison to wild type JunB, JunB K36R mutation had better protective roles in AMPA induced trophoblast dysfunctions. In conclusion, our results demonstrate that AMPA exposure promotes lactate production via the PPARγ/ANGPTL4 pathway, which subsequently inhibits the proliferation, migration and invasion of trophoblasts through JunB K38 lactylation, ultimately leading to SA. Show less
no PDF DOI: 10.1016/j.ecoenv.2025.118743
ANGPTL4
Bolun Li, Yanjiang Xing, Yitian Zhou +10 more · 2025 · bioRxiv : the preprint server for biology · Cold Spring Harbor Laboratory · added 2026-04-24
Animal models are used widely to study pulmonary hypertension (PH). The cell populations that respond to disease-inducing stimuli in these models and their relationship to human disease remain incompl Show more
Animal models are used widely to study pulmonary hypertension (PH). The cell populations that respond to disease-inducing stimuli in these models and their relationship to human disease remain incompletely defined. This study analyzed the relationship between several rodent models of PH and human disease at single-cell resolution. scRNA-seq was performed on lungs from mice exposed to hypoxia or Sugen/hypoxia, rats exposed to monocrotaline, and controls. A cross-species single-cell dataset was integrated with human lung cell atlas (HLCA) and single-cell dataset from idiopathic pulmonary arterial hypertension (IPAH) to identify overlapping cell subsets between experimental and human disease and species. High levels of overlap were found between species and models of PH, HLCA, and IPAH datasets. Cell subsets perturbed in rat and mouse PH were similar to those found in human disease, with macrophages and endothelial cells being most affected. A novel We established a comprehensive cross-species single-cell atlas of mainstream rodent PH models, highlighting several novel macrophage and endothelial subtypes and signaling motifs potentially contributing to human disease. Show less
no PDF DOI: 10.1101/2025.04.30.651587
ANGPTL4
Chunhong Yao, Jinfeng Wang · 2025 · Scientific reports · Nature · added 2026-04-24
The aim of this study was to investigate the effects and mechanisms of ANGPTL4 on cognitive impairment in vascular dementia rats. 36 SD rats were randomly divided into Sham(n= 9), VaD(n= 9), VaD + ANG Show more
The aim of this study was to investigate the effects and mechanisms of ANGPTL4 on cognitive impairment in vascular dementia rats. 36 SD rats were randomly divided into Sham(n= 9), VaD(n= 9), VaD + ANGPTL4 OE(n= 9), and VaD + ANGPTL4 KD(n= 9). A bilateral carotid artery ligation (2-VO) rat VaD was established to study the effects of ANGPTL4. Spatial memory was tested in rats using the Morris water maze. Morphological changes of neurons were detected in the CA1 region of the hippocampus by hematoxylin-eosin staining. The expression of ANGPTL4, p-Syk in the cells of hippocampal CA1 area was also detected by immunohistochemistry. Afterwards, protein expression of ANGPTL4, p-Syk, p-JNK, BNIP3 was detected by Western blot (WB). Afterwards, the mechanism of ANGPTL4 effect on cognitive impairment in vascular dementia rats was further explored by ANGPTL4 OE hippocampal cells 1%O Show less
📄 PDF DOI: 10.1038/s41598-025-07811-y
ANGPTL4
Dou Yin, Nana Fang, Yaling Zhu +8 more · 2025 · Journal of experimental & clinical cancer research : CR · BioMed Central · added 2026-04-24
The adipocyte-rich tumor microenvironment (TME) is recognized as a key factor in promoting cancer progression. A distinct characteristic of peritumoral adipocytes is their reduced lipid content and th Show more
The adipocyte-rich tumor microenvironment (TME) is recognized as a key factor in promoting cancer progression. A distinct characteristic of peritumoral adipocytes is their reduced lipid content and the acquisition of a proinflammatory phenotype. However, the underlying mechanisms by which adipocytes rewire metabolism and boost tumor progression in triple-negative breast cancer (TNBC) remain poorly understood. We utilized transcriptomic analysis, bioinformatic analysis, metabolic flux analysis, protein-protein docking, gene and protein expression profiling, in vivo metastasis analysis and breast cancer specimens to explore how adipocytes reprogram tumor metabolism and progression in TNBC. Our findings reveal that Angiopoietin-like 4 (ANGPTL4) exhibits significantly higher expression levels in adipocyte-rich tumor circumstance compared to the symbiotic environment lacking of adipocyte. Furthermore, ANGPTL4 expression in tumor cells is essential for adipocyte-driven glycolysis and metastasis. Interleukin 6 (IL-6), enriched in cancer-associated adipocytes, and lipolysis-derived free fatty acids (FFAs) released from adipocytes, amplify ANGPTL4-mediated glycolysis and metastasis through activation of STAT3 and PPARα pathways in TNBC cells. Additionally, ANGPTL4 interacts with transcription factor KLF4 and enhances KLF4 activity, which further drives glycolysis and metastasis, whereas KLF4 knockdown attenuates migration and glycolysis in TNBC cells. Importantly, Elevated ANGPTL4 and KLF4 expression was observed in metastatic breast cancer specimens compared to non-metastatic cases and was positively correlated with poor prognosis. Collectively, our results uncover a complex metabolic interaction between adipocytes and TNBC cells that promotes tumor aggressiveness. ANGPTL4 emerges as a key mediator in this process, making it a promising therapeutic target to inhibit TNBC progression. Show less
📄 PDF DOI: 10.1186/s13046-025-03458-9
ANGPTL4
Xiaojun Wang, Hung-Chen Chang, Xuchao Gu +2 more · 2025 · Clinical interventions in aging · added 2026-04-24
The angiopoietin-like protein 4 (ANGPTL4), also known as fasting-induced adipose factor, is a secreted glycoprotein that belongs to the ANGPTL protein family. Due to its expression in various cell typ Show more
The angiopoietin-like protein 4 (ANGPTL4), also known as fasting-induced adipose factor, is a secreted glycoprotein that belongs to the ANGPTL protein family. Due to its expression in various cell types and tissues and its interactions with other proteins, ANGPTL4 plays diverse roles within its family, exhibiting a wider range of molecular functions. For instance, ANGPTL4 is intricately involved in modulating central energy metabolism and enhancing exercise endurance, while also acting as a pivotal mediator in the interaction between gut microbiota and host lipid metabolism. Moreover, the expression of ANGPTL4 is directly controlled by aging-related signaling pathways. Its excessive activation accelerates the aging process by triggering mechanisms like heightened oxidative stress, epithelial-mesenchymal transition (EMT) and fibrosis, abnormal lipid accumulation, and cellular arrest, thereby advancing the development of age-related diseases. Given the pivotal roles of ANGPTL4 and its associated molecules in organ fibrosis and cancer advancement, targeting ANGPTL4 emerges as a promising therapeutic approach. However, the intricate and sometimes conflicting functions of the two cleavage fragments of ANGPTL4, namely N-terminal fragment (nANGPTL4) and C-terminal fragment (cANGPTL4), in different chronic diseases-exerting inhibitory or stimulatory effects depending on the disease stage-have posed challenges to the progress of ANGPTL4 antibody therapy. This review provides an overview of the biological mechanisms of ANGPTL4, its dual impact on fibrosis and tumorigenesis, and highlights its recent advancements as a potential biomarker in age-related diseases and inflammation-related conditions. ANGPTL4 is a high-potential but complex target, requiring mechanism-driven strategies for safe clinical translation. Show less
📄 PDF DOI: 10.2147/CIA.S522049
ANGPTL4
Fei Lu, Lan Li, Li Wang +6 more · 2025 · Discover oncology · Springer · added 2026-04-24
This study aims to comprehensively analyze the genetic characteristics and prognostic value of stemness- and epithelial-mesenchymal transformation (EMT)-related gene signatures in lung adenocarcinoma Show more
This study aims to comprehensively analyze the genetic characteristics and prognostic value of stemness- and epithelial-mesenchymal transformation (EMT)-related gene signatures in lung adenocarcinoma (LUAD). The RNA-sequencing transcriptome profiling data and corresponding clinical information of LUAD were procured from TCGA-LUAD and GEO datasets. After screening, we first obtained 1488 stemness- and EMT-related genes. Then 304 hub genes were obtained via WGCNA, of which 52 genes were established to be prognosis-related hub genes. Thereafter, a prognostic model containing 11 genes (ANGPTL4, CCL20, ENO1, FGF2, LGR4, PIM2, S100P, SATB2, SHOX2, ZNF322, and CFTR) was constructed. We demonstrated that a higher risk score was an independent negative prognostic factor in LUAD patients. A nomogram was further constructed to better predict the survival of LUAD patients. More importantly, we found that the low-risk group has a more favorable anti-tumor immune microenvironment and may benefit more from immunotherapy. We finally noticed that the high-risk group was more sensitive to most drugs including drugs commonly used to treat LUAD patients. In conclusion, this study has summarized the alterations and prognostic role of stemness- and EMT-related gene signatures in LUAD and constructed a prognostic model to accurately and stably predict survival and guide individualized treatment decisions. Show less
📄 PDF DOI: 10.1007/s12672-025-02866-9
ANGPTL4
Xiaobin Mai, Le Wang, Juan Tu +13 more · 2025 · Genes & diseases · Elsevier · added 2026-04-24
📄 PDF DOI: 10.1016/j.gendis.2025.101681
ANGPTL4
James Yarmolinsky, Matthew A Lee, Evelyn Lau +25 more · 2025 · Journal of the National Cancer Institute · Oxford University Press · added 2026-04-24
The role of lipid-perturbing medications in cancer risk is unclear. We employed cis-Mendelian randomization and colocalization to evaluate the role of 5 lipid-perturbing drug targets (ANGPTL3, ANGPTL4 Show more
The role of lipid-perturbing medications in cancer risk is unclear. We employed cis-Mendelian randomization and colocalization to evaluate the role of 5 lipid-perturbing drug targets (ANGPTL3, ANGPTL4, APOC3, CETP, and PCSK9) in risk of 5 cancers (breast, colorectal, head and neck, ovarian, and prostate). We triangulated findings using pre-diagnostic protein measures in prospective analyses in EPIC (977 colorectal cancer cases, 4080 sub-cohort members) and the UK Biobank (860 colorectal cancer cases, 50 177 controls). To gain mechanistic insight into the role of ANGPTL4 in carcinogenesis, we examined the impact of the ANGPTL4 p. E40K loss-of-function variant on differential gene expression in normal colon tissue in BarcUVa-Seq. Finally, we evaluated the association of colon tumor ANGPTL4 expression with cancer-specific mortality in TCGA. In analysis of 78 473 cases and 107 143 controls, genetically proxied circulating ANGPTL4 inhibition was associated with reduced colorectal cancer risk (ORSD decrease = 0.76, 95% confidence interval [CI] = 0.66 to 0.89, P = 5.52 × 10-4, PPcolocalization = 0.83). This association was replicated using pre-diagnostic circulating ANGPTL4 concentrations in EPIC (hazard ratio [HR]log10 decrease = 0.91, 95% CI = 0.84 to 0.98, P = .01) and the UK Biobank (HRSD decrease = 0.93, 95% CI = 0.86 to 0.99, P = .03). In gene-set enrichment analysis of differential gene expression in 445 colon tissue samples, ANGPTL4 loss-of-function down-regulated several cancer-related biological pathways (PFDR < .05), including those involved in cellular proliferation, epithelial-to-mesenchymal transition, and bile acid metabolism. In analysis of 465 colon cancer patients, lower ANGPTL4 tumor expression was associated with reduced colorectal cancer-specific mortality risk (HRlog2 decrease = 0.66, 95% CI = 0.50 to 0.87, P = 2.92 × 10-3). Our integrative proteogenomic and observational analyses suggest a potential protective role of lower circulating ANGPTL4 concentrations in colorectal cancer risk. These findings support further evaluation of ANGPTL4 as a therapeutic target for colorectal cancer prevention. Show less
📄 PDF DOI: 10.1093/jnci/djaf137
ANGPTL4
Yang Zhang, Xuyang Yang, Su Zhang +10 more · 2025 · JCI insight · added 2026-04-24
The prognosis for colorectal cancer (CRC) patients with liver metastasis remains poor, and the molecular mechanisms driving CRC liver metastasis are not fully understood. Tumor-derived hypoxia-induced Show more
The prognosis for colorectal cancer (CRC) patients with liver metastasis remains poor, and the molecular mechanisms driving CRC liver metastasis are not fully understood. Tumor-derived hypoxia-induced extracellular vesicles have emerged as key players in inducing angiogenesis by transferring noncoding RNAs. However, the specific role of CRC-derived hypoxic extracellular vesicles (H-EVs) in regulating premetastatic microenvironment (PMN) formation by inducing angiogenesis remains unclear. Our study demonstrates that H-EVs induce angiogenesis and liver metastasis. Through microRNA microarray analysis, we identified a reduction in miR-6084 levels within H-EVs. We found that miR-6084 inhibited angiogenesis by being transferred to endothelial cells via EVs. In endothelial cells, miR-6084 directly targeted angiopoietin like 4 (ANGPTL4) mRNA, thereby suppressing angiogenesis through the ANGPTL4-mediated JAK2/STAT3 pathway. Furthermore, we uncovered that specificity protein 1 (SP1) acted as a transcription factor regulating miR-6084 transcription, while hypoxia-inducible factor 1A (HIF1A) decreased miR-6084 expression by promoting SP1 protein dephosphorylation and facilitating ubiquitin-proteasome degradation in SW620 cells. In clinical samples, we observed low expression of miR-6084 in plasma-derived EVs from CRC patients with liver metastasis. In summary, our findings suggest that CRC-derived H-EVs promote angiogenesis and liver metastasis through the HIF1A/SP1/miR-6084/ANGPTL4 axis. Additionally, miR-6084 holds promise as a diagnostic and prognostic biomarker for CRC liver metastasis. Show less
📄 PDF DOI: 10.1172/jci.insight.189503
ANGPTL4
Taotao Yan, Mingyang Jia, Jiaxi Li +6 more · 2025 · Frontiers in veterinary science · Frontiers · added 2026-04-24
The Huainan pig (HN) is known for its impressive litter size and exquisite meat quality. However, it also exhibits certain drawbacks such as excessive fat deposition, a relatively low percentage of le Show more
The Huainan pig (HN) is known for its impressive litter size and exquisite meat quality. However, it also exhibits certain drawbacks such as excessive fat deposition, a relatively low percentage of lean meat percentage, and a slower growth rate. Crossbreeding with lean-type breeds, such as Large White, Landrace, and Berkshire can enhance offspring traits, and increase genetic diversity. In this study we employed RNA-seq technology to identify differentially expressed genes (DEGs) in subcutaneous adipose tissue (SAT) samples from HN pigs and their crosses with multiple breeds (with three replicates per group). In the SAT of Huainan × Berkshire pigs (BH), Huainan × Yorkshire pigs (YH), and Huainan × Landrace pigs (LH), numerous key functional genes were identified, including In conclusion, these findings offer valuable insights and provide a foundation for future research on the molecular mechanisms underlying fat deposition in pigs. Show less
📄 PDF DOI: 10.3389/fvets.2025.1545694
ANGPTL4
Yutong Jin, Yao Wang, Chuan Wang +7 more · 2025 · Chinese journal of natural medicines · Elsevier · added 2026-04-24
This study investigated the regulatory potential of salidroside (SAL), a primary active compound in Rhodiola rosea L., on osteoclast differentiation by modulating the hypoxia-inducible factor 1-alpha Show more
This study investigated the regulatory potential of salidroside (SAL), a primary active compound in Rhodiola rosea L., on osteoclast differentiation by modulating the hypoxia-inducible factor 1-alpha (HIF-1a) pathway in osteoblasts. Luciferase reporter assay and chromatin immunoprecipitation (ChIP) assay were employed to validate whether the receptor activator of nuclear factor-?B ligand (RANKL) is the downstream target gene of HIF-1a in osteoblasts. The study also utilized lipopolysaccharide (LPS)-induced mouse osteolysis to examine the impact of SAL on osteolysis in vivo. Furthermore, conditioned medium (CM) from SAL-pretreated osteoblasts was used to investigate the paracrine effects on osteoclastogenesis through the HIF-1a pathway. Hypoxic condition-induced overexpression of HIF-1a upregulated RANKL levels by binding to the RANKL promoter and enhancing transcription in osteoblastic cells. In vivo, SAL significantly alleviated bone tissue hypoxia and decreased the expression of HIF-1a by downregulating the expression of RANKL, vascular endothelial growth factor (VEGF), interleukin 6 (IL-6), and angiopoietin-like 4 (ANGPTL4). In the paracrine experiment, conditioned media from SAL-pretreated osteoblasts inhibited differentiation through the HIF-1a/RANKL, VEGF, IL-6, and ANGPTL4 pathways. RANKL emerges as the downstream target gene regulated by HIF-1a in osteoblasts. SAL significantly alleviates bone tissue hypoxia and bone loss in LPS-induced osteolysis through the HIF-1a/RANKL, VEGF, IL-6, and ANGPTL4 pathways. SAL inhibits osteoclast differentiation by regulating osteoblast paracrine secretion. Show less
no PDF DOI: 10.1016/S1875-5364(25)60864-8
ANGPTL4
Jing-Yi Wang, Yao-Hui Liu, Xiao Wang +7 more · 2025 · Arthritis research & therapy · BioMed Central · added 2026-04-24
Meniscus degeneration contributes to knee arthritis progression, but the cellular and molecular mechanisms of meniscus aging remain poorly understood. We aimed to characterize age-related changes in t Show more
Meniscus degeneration contributes to knee arthritis progression, but the cellular and molecular mechanisms of meniscus aging remain poorly understood. We aimed to characterize age-related changes in the rat meniscus using single-cell RNA sequencing (scRNA-seq) and identify key pathogenic cell populations and pathways. Meniscal tissues from young (12 weeks) and aged (24 months) rats were processed for histology, flow cytometry, and scRNA-seq. Bioinformatics tools, including Seurat, Monocle 2, and CellChat, were used to analyze cellular composition, pseudotime trajectories, and intercellular communication. Senescence-related features and signaling pathways were evaluated. Knee joint of aged rats exhibited higher Osteoarthritis Research Society International (OARSI) scores and synovial inflammation. scRNA-seq revealed three major chondrocyte subpopulations: Sox9 + stable chondrocytes, Fndc1 + fibrochondrocytes, and Atf3 + senescent chondrocytes. Aging caused a significant increase in Atf3 + senescent chondrocytes, characterized by the expression of senescence markers (Cdkn1a/Cdkn2a) and activation of inflammatory pathways such as tumor necrosis factor (TNF) and nuclear factor-κB (NF-κB). These cells were predominantly located at the endpoint of differentiation trajectories. CellChat analysis identified the ANGPTL4-SDC4 axis as a key signaling pathway mediated by Atf3 + cells. Immunostaining confirmed elevated Angiopoietin-Like Protein 4 (ANGPTL4) expression in aged menisci. We identified Atf3 + senescent chondrocytes as a key pathogenic population in the aging meniscus, driving degeneration via the ANGPTL4 pathway. Targeting Atf3 + cells or ANGPTL4 signaling may offer new therapeutic strategies for age-related meniscus degeneration and arthritis. Show less
📄 PDF DOI: 10.1186/s13075-025-03566-z
ANGPTL4